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ABSTRACT
HMGBl (High mobility group 1 protein) is both a nuclear factor and a secreted 
protein. In the cell nucleus it acts as an architectural chromatin-binding factor that bends 
DNA and promotes protein assembly on specific DNA targets. Outside the cell, it binds 
with high affinity to RAGE (receptor for advanced glycation endproducts), and is a 
potent mediator of inflammation.
I used a GFP-fused HMGBl in combination with photobleaching techniques to 
characterize the binding of the protein to chromatin. I found that the protein has 
differential chromatin binding properties in living, apoptotic, and necrotic cells. In 
living cells, HMGBl exchanges rapidly between the soluble and the chromatin-bound 
states. In necrotic cells, HMGBl is not associated with chromatin and is leaked into the 
extracellular medium. In apoptotic cells, HMGBl is retained in the nucleus because it 
binds stably to chromatin, in a process that can be inhibited by trichostatin A and 
appears to be a consequence of histone H4 deacetylation.
The differential binding of HMGBl to chromatin in necrotic and apoptotic cells is 
relevant with reference to the role of HMGBl in promoting inflammation: as necrosis is 
always accompanied by inflammation in contrast to apoptosis, we made the hypothesis 
that HMGBl, released by necrotic cells but retained by apoptotic ones, could be used by 
proinflammatory cells as a signal to distinguish necrosis from apoptosis. Indeed, 
necrotic cells lacking HMGBl are rather ineffective in activating proinflammatory cells, 
and injections of anti-HMGBl antibodies in wt'mice reduce inflammatory responses 
induced by liver necrosis, indicating that HMGBl is necessary to promote inflammatory 
responses to necrosis. Moreover, if HMGBl is detached from apoptotic chromatin by 
TSA treatment, also apoptotic cells become proinflammatory.
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Thus, HMGBl acts as a signal of unprogrammed cell death, and the retention of 
HMGBl by apoptotic cells appears to be a safeguard mechanism to prevent unwanted 
inflammatory reactions in response to programmed cell death.
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SUMMARY
High Mobility Group 1 (HMGBl) is an abundant and ubiquitous chromatin 
protein present in all vertebrate nuclei. It is endowed with a DNA bending activity 
which makes it act as an architectural chromatin factor: though it has no sequence 
specificity, it is recruited by several DNA-binding proteins to bend the DNA, thereby 
promoting the formation of multiprotein complexes on specific DNA targets.
Surprisingly, recent data have established that beyond its intranuclear function, 
HMGBl also has a pivotal function outside of the cell, as an extracellular signal. A 
receptor for HMGBl exists (RAGE, receptor for advanced glycation endproducts), and 
upon binding to the receptor, HMGBl acts as a potent mediator of inflammation and 
cell migration.
My thesis work aimed to understand how the intracellular and the extracellular 
roles of HMGBl are linked to each other, and starting from the analysis of the 
chromatin binding properties of HMGBl, it culminates with the proposal that the 
passive release of this abundant chromatin protein by dead cells may represent a 
“danger signal” which activates the immune system.
I used a GFP-fused HMGBl in combination with photobleaching techniques to 
characterize the binding of the protein to chromatin. I found that the protein has 
differential chromatin binding properties in living, apoptotic, and necrotic cells. In 
living cells, HMGBl exchanges rapidly between the soluble and the chromatin-bound 
states both in mitosis and in interphase. Fluorescence recovery after photobleaching 
(FRAP) and Fluorescence loss in photobleaching (FLIP) experiments have shown that 
HMGBl moves very rapidly within the nucleus and binds to chromatin transiently, with 
extremely fast dissociation/association kinetics. In necrotic cells, HMGBl is not
associated with chromatin and is rapidly leaked from chromatin into the extracellular 
medium as soon as membrane integrity is lost. In apoptotic cells, HMGBl is retained in 
the nucleus because it binds non-covalently, but stably, to chromatin. FRAP and FLIP 
analysis have shown that in apoptosis HMGBl is almost immobile and sticks to 
chromatin, and even late apoptotic cells, undergoing autolysis, do not release the 
protein.
In order to elucidate the molecular mechanism underlying the stable association 
of HMGBl with chromatin in apoptosis, I checked for possible post-translational 
modifications of the protein in apoptotic cells. By 2D gel analysis, no difference in the 
pi or in the molecular weight of HMGBl was observed comparing living and apoptotic 
cells, indicating that the protein may not be differentially modified in apoptosis. Instead, 
the causes of HMGBl binding to chromatin are likely to be chemical and structural 
alterations in chromatin that create stable binding sites for HMGBl. In particular, 
histone H4 is deacetylated during apoptosis, and the inhibition of this deacetylation by 
tricostatin A treatment abolishes HMGB 1 binding to chromatin.
The differential binding of HMGBl to chromatin in necrotic and apoptotic cells is 
relevant with reference to the role of HMGBl in promoting inflammation: necrosis is an 
unprogrammed mode of cell death and the primary response to necrosis is 
inflammation; .in contrast, apoptosis is a physiological and programmed process and 
apoptotic cells only need physical removal and do not cause inflammatory response. We 
made the hypothesis that HMGBl could be used by proinflammatory cells as a signal to 
distinguish necrosis and apoptosis. Indeed, necrotic cells lacking HMGBl are rather 
ineffective in activating proinflammatory cells, and injections of anti-HMGBl 
antibodies in wt mice reduce inflammatory responses induced by liver necrosis, 
indicating that HMGBl is necessary to promote the inflammatory response to necrosis.
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Moreover, if HMGBl is detached from apoptotic chromatin by TSA treatment, also 
apoptotic cells become proinflammatory.
The conclusion deriving from this work suggests that the retention of HMGBl by 
apoptotic cells might be a mechanism to prevent unwanted inflammatory reactions in 
response to programmed cell death: necrotic cells release HMGBl, thus informing the 
neighbour cells of their traumatic demise, and promoting inflammation; cells 
undergoing apoptosis, instead, withhold the signal, retaining HMGB 1 tightly bound to 
chromatin, and they avert in this way inflammatory responses.
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1 INTRODUCTION
1.1 HMGB proteins (High Mobility Group Box)
The HMGB family comprises in mammals the three proteins HMGBl 
(previously, HMGl), HMGB2 (previously, HMG2) and HMGB3 (previously, HMG4 or 
HMG2b) (Bustin, 2001). HMGB proteins are very abundant, non-histone chromatin 
proteins present in the nucleus of all eukaryotic cells. They are small proteins (~ 25 
KDa) characterised by high mobility in denaturing SDS polyacrylamide gels, hence the 
acronym High Mobility Group (Bustin et al., 1990).
HMGBl is the archetypal member of the group and gives the name to the family. 
It is ubiquitous and only 10 times less abundant than core histones, counting about one 
million molecules per typical mammalian cell. The expression of the other two family 
members is more restricted: HMGB3 is only expressed to a significant amount during 
embryogenesis (Vaccari et al., 1998); HMGB2 is widely expressed during embryonic 
development, but restricted mainly to lymphoid organs and testis in the adult mouse 
(Ronfani et al., 2001).
The structure of these three proteins is highly conserved (Fig. 1) (more than 80% 
amino acid identity), and their biochemical properties are so far indistinguishable. 
HMGBs are composed of three different domains. The two homologous DNA binding 
domains, HMG box A and B, are each around 75 amino acids in length. The C-terminal 
domain is highly negatively charged, consisting of a continuous stretch of glutamate or 
aspartate residues, and is longest in HMGBl and shortest in HMGB3 (reviewed in 
Bianchi and Beltrame, 2000; Bustin, 1999).
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box A boxB acidic tail
HMGBl Nj 
HMGB2 n | 
HMGBS N
C 215 aa
C 209 aa
200 aa
Fig. 1 Structure of HMGB proteins. All HMGBs possess two DNA binding domains, HMG 
box A and B (black boxes), and an unstructured acidic tail of variable length at the C-terminus 
(grey box).
Putative counterparts of HMGBs are present in Saccharomyces cerevisiae (non­
histone proteins 6A and 6B, NHP6A and NHP6B) (Kolodrubetz and Burgum, 1990) 
and Drosophila melanogaster (HMG-D and HMG-Z) (Wagner et al., 1992), as well as 
in plants (Fig. 2A). Single HMG-box domains, with no acidic tail, characterize also an 
increasing number of mammalian sequence-specific transcription factors, such as the 
sex determining factor SRY (sex-determining region Y) (Goodfellow and Lovell- 
Badge, 1993) and the lymphocyte enhancer factor 1 (LEF-1) (Verbeek et al., 1995).
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1.2 The HMG-box domain
All the known biochemical and functional properties of HMGBs are specified by 
their HMG-boxes. The HMG-box motif is a stretch of about 75 residues, with a net 
positive charge and rich in aromatic residues and prolines (Bianchi et al., 1992). No 
amino acid is absolutely conserved in all known HMG-boxes, and only three residues 
have conservative substitutions.
The three-dimensional structures of several HMG-boxes have been resolved by 
means of either NMR or crystallography, showing that the global fold of the domain is 
well conserved (Read et al., 1993; Hardman et al., 1995; Weir et al., 1993; Jones et al., 
1994; Werner et al., 1995). The HMG-box of HMGBl consists of three a-helical 
segments forming an L-shaped structure stabilised by a hydrophobic core. The shorter 
arm of the "L" consists of helices I and II and the longer arm is composed of the 
extended N-terminal section packed against the C-terminal region, helix III (Fig. 
2B,C).
Despite having a broadly similar fold, the structures of the A and B domains of 
HMGB 1 differ significantly in the relative disposition of helices I and II and in the 
trajectory of the helix I-II loop. In box A, helix I is essentially straight whereas in box 
B it is bent, and the loop between helices I and II is longer in box A than in box B.
The HMG boxes of HMGBl are highly similar to the HMG domains of S. cerevisiae 
NHP6A and Drosophila HMG-D and, to a lesser extent, to the sequence-specific (e.g. 
SRY and LEF-1) HMG-boxes.
14
1 (X) (Y)
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A domain 6 domain HMG-0 domain A domain B domain HMG-D domain
Fig. 2 Comparison between amino acid sequences and folds of different HMG boxes.
A. Residues of non-sequence-specific and sequence-specific HMG boxes intercalating into the 
DNA minor groove (marked in red and indicated as X and Y) are localised with respect to the 
a-helices determined by NMR spectroscopy for HMGBl box A (shown in green above the 
sequence) and the sequence-specific LEF-1 HMG box (shown in blue below the sequence). 
Prefixes r, h and m signify rat, human and mouse, respectively.
B. Location of residues at X and Y m the 3D structures of HMGBl box A, HMGBl box B 
(inferred intercalations) and the HMG-box of HMG-D.
C. Solution structures of the A and B HMG boxes of HMGB 1 and of the HMG box of 
HMG-D, determined by NMR spectroscopy (Hardman et al., 1995; Weû et al., 1993; Jones et 
al., 1994). The structures are oriented to show the differences in the relative disposition of 
helices I and II between the different domains.
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The main feature of the HMG-boxes of HMGBl is the ability to both recognise 
and produce distorted structures in DNA. HMGBl binds rather inefficiently to linear 
DNA, with no preference for any nucleotide sequence. It shows, on the contrary, high 
affinity and selectivity to structured DNA, such as 4-way junctions, cisplatin-DNA 
adducts, and kinked DNA (Bianchi et al., 1989,1992). The binding of HMGBl to DNA 
is therefore sequence-independent, but structure-specific. Beyond the ability to 
recognise distorted structures, HMGBl can also introduce them in the double helix, 
thanks to a DNA bending activity. In spite of its low affinity for linear DNA, when 
present at high concentrations, HMGBl is capable of inducing DNA bends upon 
binding, as revealed by ring closure of short DNA fragments (Pil et al., 1993).
As yet, no structure of a complex between HMGBl and linear DNA has been 
solved. However, the similarity with other HMG-boxes, for which structural data are 
available (Werner et al., 1995; Murphy et al., 1999), is revealing with respect to the 
mechanism underlying HMGBl-mediated DNA bending. The DNA-binding surface of 
the HMG box domain has a hydrophobic surface that conforms to a wide, shallow 
minor groove. In the centre of this surface, a hydrophobic wedge, usually consisting of 
four spatially close residues, inserts deep into the minor groove. This partial 
intercalation introduces a kink into the bound DNA, enhancing the more uniform bend 
associated with the widening of the minor groove (Fig. 3A). The only resolved 
complex between HMGBl and a DNA substrate is the X-ray structure of the rat HMG- 
box A domain complexed to cisplatin-modified DNA (Fig. 3B) (Ohndorf et al., 1999). 
Cisplatin is a drug that damages DNA, creating intrastrand crosslinks between adjacent 
purines (Pil and Lippard, 1992). These crosslinks bend and unwind the duplex, 
generating a structure which HMGBl binds with high affinity, without inducing any
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further distortion. The analysis of the complex revealed which amino acids are mainly 
involved in contacts with DNA: particularly important appeared to be a phenylalanine 
residue in helix II (see Fig. 2A,B), which intercalates into the kinked platinated GpG 
site, and whose substitution dramatically reduces the binding of the domain. 
Nevertheless, the cisplatin-induced intrastrand crosslinks alter the contact surface for 
the HMG box on DNA, compared to a linear molecule, and indeed significant 
differences are observed with respect to LEFl- and SRY-DNA complexes. These 
proteins induce in DNA a bend similar to the one formed at the kinked platinated site, 
but the bend locus in this case is near the centre of the protein-binding site. In contrast, 
the binding surface of HMGBl box A extends exclusively to the 3' side of the bend, 
when the platinated strand is used as a reference, and it covers five base-pair steps (Fig. 
3B). Thus, the relationship between the DNA bend and the protein-binding site is 
slightly altered by the cisplatin-induced intrastrand crosslinks. Taking this into account, 
and considering that the general fold of all HMG boxes is well conserved, a complex 
between the HMG box of HMGBl and a linear DNA is likely very similar to those 
formed by the sequence-specific HMG boxes (Fig. 3C).
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SRY box-DNA HMGBl boxA-c/s-Pt DNA HMGBl box-DNA
Fig. 3 Structures of HMG box-DNA complexes.
A. Structure of the complex between the HMG box (red) of human SRY and the octanucleotide 
GCACAAAC (blue). The DNA is significantly distorted: the minor groove is widened 
considerably to accommodate the extended stretch of the HMG box; the planes of the bases are 
tilted, and the double helix is unwound and bent. The contact between the HMG box and the 
DNA occurs over a surprisingly large area and with a very tight fit; thus, the energetic cost of 
distorting the DNA is more than compensated by the chemical energy fi-eed by the protein-DNA 
interaction (Werner et al., 1995).
B. The complex of the HMGBl box A with cis-platinated DNA (X-ray crystal structure) 
(Ohndorf et al., 1999). Remarkably, in this structure the orientation of the intercalating Phe 
group differs fi'om that in the solution structure of the fi^ ee domain shown in Fig. 2B.
C. Model of HMGBl box B positioned on 15 bp of DNA. The model is derived from the high 
similarity between sequence-specific HMG boxes and the HMGB boxes of HMGBl. The 
electrostatic surface (blue is positive charge; red is negative charge) is shown with the 
intercalating phenylalanine residue in yellow. DNA strands are shown in magenta and cyan 
(Wolffe, 1999).
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1.3 HMGB proteins as architectural regulators
Many studies have been performed over the last few years in the attempt to 
correlate the characteristic DNA-binding properties of the HMG-box domain to the 
biological roles of the abundant HMGB proteins. One proposed general function of 
these proteins is to overcome the barrier imposed by the axial rigidity of DNA and 
thereby promote the formation of complex nucleoprotein assemblies containing tightly 
bent DNA (Crothers, 1993). Such a role probably requires that the bend is precisely 
placed; a displacement of the binding site by even 1 bp would alter the trajectory of the 
bent DNA by 30-36°. Because DNA-sequence recognition by the abundant HMGB 
proteins lacks selectivity, the precise targeting of these proteins must depend on the 
presence of other sequence-specific DNA-binding proteins in the complex. This indeed 
appears to be the case.
HMGBl and HMGB2 have been implicated, from several in vitro assays, in both 
the activation and repression of transcription. A recurring theme is the enhancement of 
the binding of various transcription factors [e.g. Oct-1 and 2 (Zwilling et al., 1995), 
HoxD9 (Zappavigna et al., 1996), p53 (Jayaraman et al., 1998), Rel proteins (Decoville 
et al., 2000), and steroid hormone receptors (Boonyaratanakomkit et al., 1998)] to their 
cognate DNA binding sites. In most of these cases, the interaction of the HMGB protein 
with a transcription factor has been detected in vitro even in the absence of DNA, and 
could presumably serve as the mechanism for recruitment of HMGB 1,2 to particular 
DNA sites (Fig. 4). In turn, HMGB proteins bound to their partners increase the protein 
surface contacting DNA, from both the major and the minor groove, thereby achieving 
high affinity interactions. In some cases, transfection experiments have also proved 
functional interactions in vivo. The demonstrated interactions in vitro are between 
HMGBl and/or 2 and a single transcription factor. However, it is probable that in vivo,
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in a natural regulatory context, the DNA bending by HMGBl or 2 may allow the 
recruitment of a second transcription factor to the complex, generating a complex 
network of interactions (Fig. 4).
In vitro interactions between HMGB proteins and the basal transcription 
machinery have also been reported. Human HMGBl binds to the TATA-box binding 
protein (TBP) and interferes with the normal binding of TFIIB in the pre-initiation 
complex, thereby inhibiting TBP function (Ge and Roeder, 1994; Sutrias-Grau et al., 
1999); both HMGBl and TFIIB independently enhance binding of TBP to TATA-box 
DNA. By contrast, HMGB2 has been reported to stabilize and activate the TBP- 
containing TFIID-TFIIA complex bound to promoter DNA (Shykind et al., 1995).
20
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TF1
+
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TF1 ^  TF1
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+
Fig. 4. A possible chaperone role for HMGBl in facilitation of transcription-factor 
binding, (a) Recruitment of HMGBl (green) to specific DNA sites through interaction with a 
sequence-specific transcription factor (TFl; red). Formation of a ternary complex that is 
probably unstable, but has been detected and/or inferred in some cases. In this ternary complex, 
HMGBl might bend the DNA, thus providing the potential for the recruitment of additional 
DNA-binding proteins (TF2; purple) to the complex (b). If no additional protein is recruited, 
HMGBl could dissociate fi*om the complex, leaving the transcription factor stably bound (c) [in 
this diagram, the final DNA is shown straight (as m the case of Oct-1 binding), but this is not 
necessarily the case; for example, the progesterone receptor bends its DNA in the binary 
complex]. Only a single HMG box is shown because the separate A and B HMG boxes of 
HMGBl have been shown to facihtate binding of various transcription factors in vitro.
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HMGB proteins exert their architectural function also in other nuclear processes 
involving manipulation of DNA structure. The best example is observed in 
lymphocytes, during V(D)J recombination, a complex process which allows the 
generation of a nearly infinite number of antibodies and T Cell Receptors. In developing 
T and B lymphocytes, antigen receptor genes are somatically assembled from several V 
(variable), D (diversity), and J (joining) DNA segments, in a process mediated by two 
lymphoid-specific enzymes, RAGl and RAG2 (products of Recombination Activating 
Genes 1-2) (Schatz et al., 1989). These proteins bind specifically to the Recombination 
Signal Sequences (RSS), regions flanking each antigen receptor segment, which direct 
the site of rearrangement. Upon binding, the RAG 1/2 complex cleaves the DNA, 
producing a hairpin intermediate with nucleotide overhangs. In the second step of the 
process, while RAG 1/2 remain stably bound to the RSS, the free ends generated by the 
cleavage are linked to each other by DNA repair activities. It has been shown that 
HMGBl and HMGB2 are recruited by RAG 1/2 to the RSS, and functionally interact 
with the complex, facilitating V(D)J recombination (Aidinis et al., 1999). Also in this 
case, a physical interaction between HMGB 1,2 and RAG 1/2 enhances the binding of 
the enzymes to the RSS. The RAG 1/2 complex possesses an intrinsic DNA bending 
activity, and upon binding, it alters the structure of the RSS site even in the absence of 
HMGB 1,2. However, the DNA bending induced by RAG 1/2 is very inefficient unless 
assisted by HMGB 1,2, suggesting a crucial contribution of HMGB proteins in 
stabilising the complex between RAG 1,2 and the bent RSS (Aidinis et al., 1999).
The picture emerging from all these data point to HMGB proteins as important 
and versatile architectural chromatin components, required for the formation and the
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stabilisation of functional nucleoprotein complexes. This function is sustained by their 
peculiar DNA binding properties and their ability to modulate the structure of DNA, 
which guarantee a correct three-dimensional assembly of DNA binding proteins on bent 
DNA.
1.4 Phenotype of HMGBl- and HMGB2- deficient mice
Mice lacking either HMGBl or HMGB2 were produced in our lab, by 
conventional knock-out, in order to study the function of the proteins in vivo (Calogero 
et al., 1999, Ronfani et al., 2001). The most dramatic phenotype is displayed by
Hmgbl'^' mice, which are bom, but die within the first day of life as a result of severe 
hypoglycaemia (Fig. 5A) (Calogero et al., 1999). While the level of glucose is
decreased in the blood of Hmgbl~^~ animals, abundant glycogen is present in their liver 
(Fig. 5B), but is not metabolised. Indeed, intraperitoneal injection of glucose in
Hmgbl~^~ newborns permits the survival of some animals, even though the rescued 
mice remain very sick, with several anatomical abnormalities (Fig. 5C).
At the cellular level, HmgbH' mice have defects in steroid hormone-dependent 
gene expression. Fibroblasts from knock-out mice transiently transfected with a reporter 
plasmid containing a GR responsive element respond weakly to the glucocorticoid
analogue dexamethasone, compared to wt fibroblasts (Fig. 5D). Moreover, CD4“^ CD8+
T cells from Hmgbl~^~ mice are partially resistant to dexamethasone exposure, while wt
CD4''" CD8+ cells undergo massive apoptosis upon treatment (Calogero et al., 1999). 
All these findings are consistent with the proposal that HMGBl helps steroid hormone 
receptors in controlling their target genes.
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Fig. 5 Hmgbl~^~ mice develop neonatal hypoglycaemia.
A. HmgbH~ mice die within the first day of life but can survive if given glucose parenterally. 
Intraperitoneal glucose injections were administered to 10 Hmgbl~/~ newborns during the first 
days after birth. Survival is indicated by a blue line. Ten HmgbH~ control mice, injected with 
saline solution, all died within day 1 (red line), similar to untreated HmgbH~ mice.
B. Periodic acid-Schiff (PAS) staining for glycogen (magenta) in livers fi-om Hmgbl~l~ mice
are shown. Despite very low blood glucose concentrations, hepatocytes of HmgbH~ mice do 
not completely mobilize glycogen (arrows, glycogen granules).
C. Phenotype of an Hmgbl~^~ spontaneous survivor at day 25. Spontaneous survivors of the 
mixed 129Sv/CDl genetic background are very similar to the most successfully glucose-
rescued Hmgbl~/~ mice of 129Sv/BALB-c background: they have a very reduced size, but 
respond positively to basic neurological tests. All spontaneous or glucose-treated surviving 
animals have sealed eyelids, arched backs, long hind paws and abnormal gait.
D. The absence of Hmgbl reduces the activity of GR in transfection assays. The expression of a 
GR-controlled reporter is reduced in H m g b l fibroblast cell lines exposed to dexamethasone.
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Unexpectedly, however, no defects in V(D)J recombination were found: even 
though the in vitro data implicate HMGBl in the process, the newborn mice have a 
normal serum abundance of immunoglobulins, and normal numbers of mature single­
positive CD4’*’, and CD8 ^ T cells expressing a complete VB repertoire in the thymus 
(Calogero et al., 1999). Moreover, in spite of the cooperation between HMGBl and 
HOX proteins and the basal transcription machinery, the gene regulation necessary to 
generate a neonatal animal with fully differentiated tissues is unimpaired in mutant 
mice.
The most plausible explanation for the lack of defects in the V(D)J products and
in the body plan of the Hmgbl~^~ mice is that HMGB2 could compensate for the 
absence of HMGB 1 in the interaction with RAG 1/2 and HOX proteins. HMGB2 is 
widely expressed during embryonic development, when HOX proteins exert their 
function, and even after birth it is particularly concentrated in the thymus, which is the 
site of V(D)J recombination. Therefore, even in the absence of HMGB 1, HOX proteins 
and RAGl/2 could find a suitable partner. By contrast HMGB2 is completely absent 
from liver in the adult, and this might explain the defects in the GR-mediated functions
and the hypoglycaemic phenotype of the Hmgbl"/' mice.
In order to test the possibility that HMGB2 might provide partial redundancy to
HMGBl, Hmgb2~/'‘ mice were also generated, with the perspective to generate double
Hmgbl"/" Hmgh2"/" mutants. Mice lacking HMGB2 are apparently healthy, and only 
show a reduced fertility in males. Increased apoptosis of germ cells in seminiferous 
tubules and production of defective spermatozoa appeared to underlie this defect (Fig. 
6 ) (Ronfani et al., 2001). This phenotype correlates with the observation that HMGB2 is 
highly abundant in the testis, even more than HMGBl.
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Fig. 6 Abnormalities in the testis of Hmgb2~/~ mice.
A. TUNEL staining for apoptotic cells in testis seminiferous tubules of Hmgb2~/~ mice, 
showing the high content of dead cells.
B. Haematoxylin-eosin stained sections of testis from a 163-day Hmgb2~/~ mouse. The regular 
periphery-to-lumen succession of spermatogonia, primary and secondary spermatocytes, 
spermatids and spermatozoa is lost, cells are separated by gaps, and degenerated Sertoli cells 
with large vacuoles are present.
C. Electron micrographs of an elongated spermatid where the acrosome (arrows) is detached 
from the nucleus, impairing its function.
Taken together, the data obtained from HMGBl- and HMGB2- deficient mice 
suggest that HMGBl and HMGB2 are indeed fimctionally equivalent, and a minimum 
total amount of HMGB 1 plus HMGB2 is required at all times. The lack of HMGB 1 is 
phenotypically more noticeable because HMGBl is ubiquitous and usually much more 
abimdant than HMGB2. In contrast, as HMGB2 has a more restricted pattern of
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expression, and in most cases HMGBl can compensate for the loss of HMGB2, the
defects in Hmgb2~/~ mice are less severe and more localised. In order to definitively 
prove the redundancy of HMGB proteins, we are currently breeding HMGBl and 2 
knockouts, to generate double mutants. So far, no double knock-out has been found at 
embryonic day 14 (p < 0.05). This result implies that HMGBl and HMGB2 have indeed 
similar functions and a sufficient amount of HMGBs is required for embryonic 
development.
1.5 HMGBl and chromatin
The most surprising finding derived from Hmgbl'/~ mice is that HMGBl is not 
essential for the life of cells, in spite of its abundance and evolutionary conservation. 
This observation impacts on the proposed role of HMGB 1 as structural protein involved 
in packaging DNA into chromatin.
For many years, HMGB proteins have been considered to cooperate with histones 
in determining chromosome architecture. Both protein families appeared to serve the 
function of wrapping DNA into arrays of repetitive modules, thereby ensuring the 
formation of organised high-order structures (Wisniewski and Grossbach, 1996; 
Zlatanova et al., 1999). On average, a typical cell nucleus contains one molecule of 
HMGBl every 10-20 nucleosomal particles, and a role for the protein in promoting the 
formation of nucleosomes has been suggested. (Travers et al., 1994). In addition, 
HMGB 1 has been proposed to stabilize nucleosomes by binding at the DNA crossover 
site (Lilley, 1992), with a function similar to that of histone HI. Indeed, HMGBl and 
histone HI share several properties. Xenopus HMGBl (xHMGl) binds to nucleosomes 
in vitro in much the same way as histone HI (Nightingale et al., 1996; Ura et al., 1996);
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the Drosophila HMGB 1-like protein HMG-D is a structural component of condensed 
metaphase chromosomes (Ner and Travers, 1994); histone HI also binds to four-way 
junctions (Varga-Weisz et ah, 1993). These observations suggested that HMGBl and 
HI could possess similar overall properties but specifically adapted to perform subtly 
different structural functions.
The first data in conflict with this model were the finding that the association of 
HMGBl with chromatin is markedly different from that of histone HI (Falciola et al., 
1994). If  cells are treated with NP-40, a non-ionic detergent which permeabilises 
plasma and nuclear membranes, nuclear proteins not tightly bound to DNA leak into the 
extracellular medium, whereas stable components of chromatin remain anchored to the 
nuclear remnants (Fig. 7A). Permeabilised cells, both in mitosis and in interphase, 
release the vast majority of HMGBl, indicating that the protein is not a structural 
component of either condensed or decondensed chromatin (Fig. 7B). On the contrary, 
histone HI remains firmly associated with DNA, as well as the core histones and other 
chromatin binding proteins. Moreover, immunofluorescence analysis showed that while 
in interphase HMGBl is uniformly distributed in the nucleoplasm, like histone HI, in 
mitosis, contrary to HI, it is totally displaced fi*om chromosomes (Falciola et al., 1994). 
In partial contrast with these observations, however, in vitro HMGBl appeared to bind 
to reconstituted nucleosomes with high affinity, forming complexes sufficiently stable 
to survive band-shift assays (Falciola et al., 1994). Thus, HMGBl can bind to 
nucleosomes, but in vivo its association with chromatin is quite loose. Taken together, 
these findings disproved a structural role of HMGB 1 in packaging bulk DNA, and 
rather suggested that the protein may establish only transient interactions with 
chromatin.
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Fig. 7 HMGBl is not stably associated to chromatin.
A. The cartoon shows what happens after NP-40 addition: both cellular and nuclear membranes 
are permeabilised and soluble proteins (blue squares and red circles) leak out from nucleus and 
cytoplasm. Thus, nuclear proteins not stably bound to DNA (red circles) are released in the 
extracellular milieu, whereas histones and other stable component of chromatin (green triangles) 
are retained in the nucleus.
B. After permeabilisation, the buffer bathing the cells (lanes 1 and 3; S: supernatant) and the 
cellular remnants, containing chromatin associated proteins (lanes 2 and 4; P: pellet) can be 
analysed by Western blot with different antibodies, to distinguish between stable components of 
chromatin and proteins that interact with DNA only transiently. While histone HI and HMGAl 
are found in the pellet, bound to DNA, HMGB 1 is released outside the cells both in interphase 
and in mitosis.
The results described above indicated that HMGBl and histone HI do not have 
equivalent functions in differentiated mammalian cells, but did not rule out the 
possibility that HMGBl might vicariate HI when the linker histone is absent. This is 
what happens in Xenopus and Drosophila, where respectively xHMGl and HMG-D
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appear to substitute for histone HI during embryogenesis (Dimitrov et al., 1994, 1993; 
Ner and Travers, 1994). Later studies addressed this problem, investigating the 
association of HMGB 1 with chromatin in very early mouse development, a period when 
histone HI is present at very low abundance (Clarke, 1992). Nonetheless, even in 
preimplantation embryos, the affinity of HMGB 1 for chromatin appeared similar to that 
observed in somatic cells, and the protein did not remain associated Avith chromosomes 
during metaphase (Spada et al., 1998). This result indicated that HMGBl has non­
overlapping roles with the linker histone and does not compensate for its absence during 
mouse early embryogenesis.
1.6 A new field of investigation: HMGBl is also an extracellular signal
In accordance with its role as an architectural component of chromatin, the 
localisation of HMGB 1 is nuclear in most cell types. Surprisingly, recent data have 
established that beyond its intranuclear function, HMGBl also has a pivotal function 
outside of the cell.
1.6.1 HMGBl as a potent mediator of inflammation
Wang et al (1999a) have recently identified HMGBl as a late mediator of 
endotoxin lethality in mice. HMGBl was found to be secreted by 
monocytes/macrophages stimulated by bacterial lipopolysaccaride (LPS, endotoxin), 
and to accumulate in the serum of the mice, mediating septic shock.
LPS is a component of all Gram-negative bacteria. It is toxic to mammals because 
it activates the innate immune system (macrophages and neutrophils) to secrete 
proinflammatory cytokines, such as TNF-a, interleukin 1 (IL-1), and macrophage
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migration inhibitory factor (MIF) (Tracey and Cerami, 1993; Bemhagen et al., 1993). 
These factors drive the acute phase response and mediate the development of shock and 
tissue injury. In recent years, therapeutic strategies for sepsis have attempted to 
modulate the excessive inflammatory response by inhibiting cytokines released by 
macrophages with specific antibodies. However, a major difficulty in targeting cytokine 
activities derives from the fact that most proinflammatory mediators are released early 
in septic shock, and inhibitors should therefore be administered immediately. In order to 
broaden the therapeutic window for sepsis, Wang et al initiated a search for a putative 
macrophage-derived mediator of lethality that appears relatively late after the onset of 
endotoxemia. This study culminated in the identification of HMGB 1 as the proposed 
late mediator of LPS lethality. The serum concentration of HMGBl significantly 
increases 16-32 hours after LPS administration in mice. Administration of anti-HMGBl 
antibodies attenuated LPS-induced endotoxemia, and conversely, injection of HMGB 1 
caused toxic shock. Moreover, septic patients showed increased serum levels of 
HMGBl, which correlated with the severity of the infection (Wang et al., 1999a).
The source of extracellular HMGBl are activated monocytes/macrophages. 
Macrophage-like RAW 264.7 cells release the protein 18 hours after stimulation with 
LPS; confirmation of the inducible nature of HMGBl release was obtained also in 
murine primary peritoneal macrophages, and in human primary peripheral blood 
mononuclear cells (Wang et al., 1999b). Pituicytes, which provide an important link 
between the immune and the neuroendocrine systems, also release HMGBl in response 
to specific stimuli like TNF-a and IL-1, suggesting that HMGBl participates in the 
regulation of neuroendocrine and immune responses to inflammatory processes (Wang 
et al., 1999b).
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Subsequently, HMGBl was also shown to cause acute lung inflammation when 
administered intratracheally (Abraham et al., 2000). Antibodies against HMGBl 
decreased lung edema and neutrophil migration, whereas they did not reduce the levels 
of the other proinflammatory cytokines, such as TNF-a, IL-lp or macrophage- 
inflammatory-protein-2 (MIP2).
It is not clear so far how HMGBl is secreted by monocytes and the other 
competent cell types: it possesses no signal peptide that would direct it to the 
endoplasmic reticulum (ER). This lack of a secretion leader peptide is a feature shared 
with a small number of other secreted proteins, like the cytokine IL-lp (Andrei et al., 
1999). Studies in murine erythroleukemia (MEL) cells have shown that HMGBl export 
does not involve the ER and the Golgi complex, but is promoted by intracellular Ca^  ^
increase and possibly by activation of a Ca-dependent PKC isoform (Passalacqua et al., 
1997).
In any case, the first event required for HMGBl secretion is nuclear export. We 
proved that HMGBl is not confined in the nucleus, but rather constantly shuttles 
between the nucleus and cytoplasm (unpublished data). The meaning of this traffic is 
still not clear; however, every time the protein goes to the cytoplasm, an opportunity 
arises to enter the secretory pathway.
Once released, HMGBl is able to activate several other cells involved in the 
immune response or inflammatory reactions, and can act as a cytokine itself (Andersson 
et al., 2000). HMGBl activates monocytes to secrete a specific subset of 
proinflammatory cytokines, including TNF-a and IL-1. Stimulation occurs at the level 
of gene transcription, as cytokine mRNA levels increase after HMGBl stimulation 
(Andersson et al., 2000). In comparison with the well-knovm inflammatory stimulus
32
LPS, HMGBl causes a delayed and biphasic release of TNF-a, with a first peak at 3 
hours, followed by a second peak at 8-10 hours after HMGBl exposure.
In light of all these data, it is now clear that HMGBl has a crucial role during 
phlogystic processes: it is secreted by macrophages in response to proinflammatory 
stimuli, and also itself provokes a delayed response, thereby prolonging and sustaining 
inflammation.
1.6.2 HMGBl in differentiation processes
Before the discovery of the role of HMGB 1 in inflammation, it had already been 
observed that several cells release the protein into their surroundings as part of their 
differentiation process. Murine erythroleukemia (MEL) cells, exposed to a chemical 
inducer (hexamethyl-enebisacetamide, HMBA), release HMGBl (also called DEF for 
differentiation enhancing factor) into the medium. In turn, extracellular HMGB 1 
significantly increases the rate of MEL cell differentiation via specific binding to the 
external surface of the cell membrane (Passalacqua et al., 1997; Sparatore et al., 1996).
Likewise, HMGBl is also secreted by neurons and participates in their 
differentiation process (Pages et al., 2000, and references therein). Some years ago, an 
extracellular, membrane-bound form of HMGB 1 was purified from rat brain for its 
capability of mediating neurite outgrowth. The membrane bound form was named 
amphoterin because of its dipolar structure, but at the sequence level it is identical to 
HMGBl. Membrane HMGBl has been implicated in enhancing neurite outgroAvth in 
cerebral neurons during development, and in regenerating peripheral neurons by its 
binding to a cell surface proteoglycan, syndecan. Membrane HMGBl is abundant in 
both neuronal cell bodies and in neurites in neuroblastoma cells, whereas in neurons and
peripheral glial cells (Schwann cells) it is localised in non-nuclear compartments.
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HMGBl mRNA is developmentally regulated, and reduced significantly after the rapid 
perinatal growth phase of the rat brain. The molecular basis for cellular targeting of 
HMGBl to membranes remains unclear.
HMGBl can also be exported in the extracellular space by groups of cells which 
support the differentiation of other spatially associated cell types. Stimulated astrocytes 
release HMGB 1, which then induces LAN5 neuroblastoma cells to differentiate 
(Passalacqua et al., 1998). Human promyelocytic HL60 cells, although not secreting 
HMGBl themselves, show an accelerated differentiation when exposed to extracellular 
HMGBl (Sparatore et al., 1996).
In all these cases, the release of HMGBl into the extracellular space is well 
controlled and local: HMGBl is either secreted in an autocrine manner, or in a paracrine 
manner by closely associated cells. Remarkably, this spatially restricted secretion of 
HMGBl does not seem to trigger an inflammatory response.
1.6.3 HMGBl mediates cell migration and metastasis
HMGBl can also promote cell migration. Cells migrate in response to 
extracellular stimuli, channelled through specific signal transduction pathways, that 
ultimately elicit cytoskeletal remodelling. We showed in our lab that vascular smooth 
muscle cells respond to extracellular HMGBl (Degryse et al., 2001). Cells exposed to 
HMGBl undergo rapid and transient changes of cell shape, and actin cytoskeleton 
reorganization, leading to an elongated polarized morphology typical of motile cells.
Even more strikingly, Taguchi et al. (2000) showed that HMGBl is also involved 
in tumour growth and metastasis: administration of anti-HMGBl antibodies suppressed 
metastasis formation by Lewis lung tumour cells implanted under the skin of recipient
mice. In this context, HMGBl promotes both migration and proliferation of tumor cells.
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In vivo, cell migration depends to a large extent on the capability of a cell to 
invade the surrounding tissue, for which the activation of extracellular proteases is 
required. HMGBl appears to play a role here as well: it binds to several components of 
the plasminogen activation system and enhances the activation of t-PA (Parkkinen and 
Rauvala, 1991). Moreover, Taguchi et al. (2000) showed HMGB 1-elicited activation of 
metalloproteases MMP-2 and MMP-9, which are downstream targets of the plasmin 
activation cascade. While it enables the degradation of the extracellular matrix, the 
activation of proteases also leads to degradation of HMGB 1, and this might serve as a 
feedback mechanism.
1.6.4 Signalling mechanisms
The signalling mechanisms by which HMGBl activates cells to respond are 
incompletely understood. HMGBl is rather “sticky”, and binds to many different 
molecules on the cell surface: heparin, proteoglycans, but also sulfoglycolipids and 
phospholipids (Bianchi, 1988; Degryse et al., 2001; Rouhiainen et al., 2001). This could 
be a mechanism to restrict the diffusion of extracellular HMGBl, and thereby keep the 
effect of this potentially dangerous molecule local. HMGBl can also be taken up by the 
cell in an as yet unidentified manner, and promote the co-uptake of DNA. This property 
was therefore used to transfect cells (Mistry et al., 1997). It is however unclear whether 
binding to cell surface glycans and cellular uptake are causally related.
However, at least one high-affinity receptor for HMGBl exists: RAGE (receptor 
for advanced glycation endproducts) (Hori et al., 1995). RAGE belongs to the 
immunoglobulin superfamily and binds a variety of ligands: the glycated proteins that 
are present in the serum of diabetic patients (advanced glycation endproducts, AGEs), 
but also calgranulin, a proinflammatory peptide that derives from the proteolytic
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processing of the cytoplasmic protein SI00, and amyloid beta-peptide in Alzheimer 
patients (reviewed by Schmidt et al., 2000). It is expressed on a wide set of cells, 
including endothelial cells, smooth muscle cells, macrophages/monocytes and neurons, 
and has been implicated in several pathological processes, such as diabetes, 
amyloidoses and atherosclerosis. HMGBl binding on the cell surface itself induces the 
transcriptional upregulation of RAGE (Li et al., 1998).
The understanding of the signal transduction pathways activated by HMGB 1 
binding to RAGE is still fragmentary. Extension of neurites requires the small GTPases 
Cdc42 and Rac, but not the ras-MAP kinase pathway (Huttunen et al., 1999). However, 
in neural cells, HMGBl binding to RAGE also activates the Ras-MAP kinase pathway 
and leads ultimately to the activation of NF-kB, the transcription factor classically 
linked to inflammatory processes (Huttunen et al., 1999). During tumour invasion the 
MAP kinases p38^^^, JNK and p42/p44 MAPK have been shown to be activated by 
RAGE-HMGBl (Taguchi et al., 2000). HMGBl-mediated migration of smooth muscle 
cells also results in activation of the MAP kinase pathway and translocation of 
phosphorylated ERK 1 and 2 into the nucleus, but also involves a Gj/o protein (Degryse 
et al., 2001). How and if these pathways are linked remains an open question; moreover, 
different pathways may be activated in different cell types. One potentially interesting 
observation is that cells that respond to extracellular HMGBl appear to contain very 
little HMGB 1 themselves, and almost none in the nucleus. In support of this
observation, it has been shown that Hmgbl'^~ embryonic fibroblasts respond better to 
extracellular HMGBl in cell migration assays than their wild type counterparts (B. 
Degryse and M.E. Bianchi, unpublished data).
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The second role of HMGB 1, as an extracellular signal, has been now extensively 
documented, and is well established. Together, all the data indicate that, as in the 
nucleus, also outside the cell HMGBl is a very versatile molecule, involved in several 
processes: many cellular types can read out the HMGB 1 signal, and depending on the 
target cells very different biological responses are induced (Fig. 8 ).
inflammation
(macrophages)
differentiation
(neurons, MEL cells)
migration
(RSMC, fibroblasts)
metastasis
(tumor cells)
Fig. 8 Different biological responses induced by extracellular HMGBl. Many cells are 
equipped to recognise HMGBl in the extracellular milieu. The protein binds with moderate 
affinity to the proteoglycans covering the surface of every cell (yellow lines). In addition, high 
affinity receptors like RAGE (green structures) mediate cell-specific responses to HMGBl, 
triggering different responses, involved in physiological and pathological processes.
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1.7 HMGBl: one molecule, many functions
The discovery of the extracellular functions of HMGB 1 has opened an entirely 
new field of investigation and raised several important questions, concerning the 
mechanisms that regulate its release from the cells, the identity of all its cell surface 
receptors, and the basis for signal transduction following HMGBl stimulation. Another 
important point is understanding how the intracellular and the extracellular roles of 
HMGBl are linked to each other, and why a chromatin molecule is employed as an 
extracellular signal. My thesis work addresses part of this issue, and starting from the 
analysis of the chromatin binding properties of HMGB 1, culminates with the proposal 
that the passive release of this abundant chromatin protein by dead cells may represent a 
“danger signal” which triggers inflammation and activates the immune system.
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2 MATERIALS AND METHODS
2.1 Cell culture and induction of cell death
HeLa and 3T3 cells and embryonic fibroblasts obtained from wt and HmgbH~ 
(Calogero et al., 1999) were cultured in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% foetal bovine serum (FBS from GIB CO), 100 lU/ml of 
penicillin and 100 pg/ml streptomycin, in 5% CO2 humidified atmosphere.
Apoptosis was induced by treating the cells for 16 h with 2 ng/ml human TNF-a 
and 35 pM cycloheximide (Sigma). Human TNF-a, purified by affinity 
chromatography, was kindly provided by Flavio Cumis (Dibit, Milan).
Necrosis was induced by treatment for 16 h either with 5 pM ionomycin (Sigma) 
and 20 pM CCCP (Sigma), or 6  mM deoxyglucose (Sigma) and 10 mM sodium azide, 
in DMEM serum free. Alternatively, to avoid the presence of chemical poisons in 
cocultures with bone marrow cells, necrotic cells were obtained by 3 cycles of freeze- 
thawing in PBS (Phosphate-buffered saline), in liquid nitrogen.
2.2 Immunofluorescence
Cell cultured in LabTek II chambers (Nalgene) were washed first with PBS and 
then with. CSK buffer [10 mM Pipes-KOH, pH 7.0, 100 mM NaCl, 300 mM sucrose, 3 
mM MgCl2 (Fey et al. 1986)]. At this stage, cells were either directly fixed in 4% 
paraformaldehyde (PFA) in PBS for 10 minutes at room temperature, or subjected to 
detergent extraction. In the latter case, cells were incubated in CSK buffer
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supplemented with 0.15% Triton X-100 or NP-40, 0.5 mM PMSF (Sigma Chemical 
Co.) and 10 pg/ml leupeptin (Roche) for 1 min at room temperature. After one wash in 
CSK buffer, the cells were fixed in 4% paraformaldehyde in PBS. After fixation, cells 
were washed with PBS and incubated for 45 min with blocking solution (3% Bovine 
Serum Albumin, 0.05% Tween-20 in PBS) containing 0.1% Triton X-100 as 
permeabilising agent. Primary antibodies were then diluted in blocking solution to the 
suitable final concentration and incubation was prolonged for 45 minutes at room 
temperature. After three rinses with PBS containing 0.05% Tween-20 (PB-Tween), 
cells were incubated with secondary antibodies in blocking solution for 45 minutes, 
washed three times with PB-Tween, and finally mounted with glass coverslips using 
Vectashield (Vector Laboratories), containing 1.5 pg/ml DAPI (4’,6-diamidino-2- 
phenylindole) to stain DNA. Cells were analysed on an Axiophot microscope (Carl 
Zeiss) using Zeiss 40x, 63x and lOOx neofiuar lenses. Fluorescence photographs were 
taken on T-Max 400 film (Eastman Kodak), or digital images were acquired using a 
CCD camera (Hamamatsu Photonics) and HiPic software. The polyclonal rabbit anti- 
HMGBl was purchased from BD PharMingen (Torrey Pines, CA), and used diluted 
1:1600 in blocking solution. Monoclonal antibody against GFP (working dilution: 
1:500), and goat polyclonal antibodies against mouse or rabbit IgG (H+L) conjugated to 
fluorescein or rhodamine (working dilution: 1:300) were from Boehringer-Roche.
2.3 Differential permeabilisation of cells
HeLa cells were grown to ~ 50% confluence in 6  cm plates and forced to undergo 
apoptosis as described in paragraph 2.1. After 16 hours, apoptotic cells detached from 
the plate were collected, centrifuged 5 min at 800 rpm and washed with PBS. A control 
population of untreated living cells were recovered by tiypsinisation and centrifugation.
40
Both populations were then washed with ice-cold transport buffer (TB buffer), 
containing 20 mM Hepes, pH 7.3, 110 mM K-acetate, 5 mM Na-acetate, 2 mM Mg- 
acetate, 1 mM EGTA, 2 mM DTT, and pepstatin, antipain and leupeptin at 1 pg/ml each 
(Adam et al., 1990). Cells were incubated for 5 min on ice in 50 pi of TB buffer with 
0.1% NP-40 or 40 pg/ml digitonin (Sigma Chemical Co.), and centrifuged for 7 min at 
700 rpm. Supernatants were recovered and cell remnants were dissolved in Ix SDS- 
PAGE loading buffer (50 mM Tris pH 6 .8 , 2% 2-mercaptoethanol, 4% SDS, 12% 
glycerol, 0.05% bromophenol blue). Concentrated SDS-PAGE loading buffer was 
added also to supernatants, and samples were analysed by western blot.
In case of necrotic cells, no detergent was added to the cells. The medium from 
treated and untreated cells was collected and concentrated 50-fold using Amicon 
Ultrafree-MC filters; the cells were dissolved on the plate in SDS-PAGE loading buffer 
and analysed by Western blot.
2.4 Detection of proteins by Western blots and Coomassie staining
Samples in SDS-PAGE loading buffer were heated for 5 minutes at 100°C, and
applied to SDS polyacrylamide protein gels. The separating gel consisted of
polymerised acrylamide-bisacrylamide (ratio 29:1) in 375 mM Tris pH 8 .8 , 0.1% SDS,
at concentration variable from 1 0 % to 13%, depending on the size of the proteins to
visualise. The stacking gel consisted of 4% acrylamide-bisacrylamide, 125 mM Tris pH
6 .8 , 0.1% SDS. The running buffer contained 144 g/1 glycine, 30 g/1 Tris, 0.5% SDS.
The gels were run at 5-15 Volt/cm.
For Western blots, the proteins separated by SDS-PAGE were transferred onto
nylon Immobilon P membranes (Millipore) using a tankblot system (Hoefer) in 25 mM
Tris pH 7.5, 0.192 M glycine, 20% methanol. Blots were blocked for 1 hour at room
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temperature in 5% skim milk /TEST (20 mM Tris, pH 7.5, 137 mM NaCl, 0.1% Tween 
20), washed in TEST and incubated for 1 hour at room temperature with anti-HMGBl 
antibody (working dilution: 1:3000 in TBST/0.01% BSA). After three additional 
washes in TEST, filters were further incubated for 1 hour with an anti-rabbit antibody 
conjugated to HRP (Amersham) (1:5000 in TBST/0.01% BSA). In addition to HMGBl, 
lactate dehydrogenase (LDH) was visualized by Western blot using a goat polyclonal 
primary antibody (Chemicon, 1:500 in 5% skim milk /TEST), and a rabbit anti-goat 
IgG-HRP conjugated antibody (Santa Cruz Biotechnology). The polyclonal antibody 
RIO, a kind gift from B.M. Turner (University of Birmingham Medical School), was 
used to detected specifically the acetylated form of histone H4. After incubation with 
secondary antibodies, blots were washed with TEST and developed using the ECL 
system (Amersham).
Coomassie staining was used to detect histones. After electophoresis, gels or part 
of the gels containing histones were incubated for 45 minutes in staining solution, 
containing 45% EtOH, 8 % acetic acid, 5 g/1 Coomassie blue, and then in destain 
solution, containing 23% EtOH, 8 % acetic acid, until proteins were clearly visible. 
Gels were finally dried on 3 MM paper with a gel drier.
2.5 Two dimensional gel electrophoresis
Total extracts from ~ 10 million living and apoptotic HeLa cells were obtained by
3 cycles of freeze-thawing in 80 pi of Extraction buffer (50 mM PIPES pH 7, 50 mM
KCl, 5 mM EGTA, 2 mM MgClz, 1 mM DTT, and pepstatin, antipain and leupeptin at 1
pg/ml each). Extracts were centrifuged for 5 min at 13000 rpm to pellet membranes and
40 pi of the supernatants (total amount of proteins: about 150 pg) were added to 320 pi
of rehydration buffer, containing 8 M urea, 2% CHAPS, 20 mM dithioerythritol (DTE),
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0.8% IPG buffer (carrier ampholytes, pH 3-10, Pharmacia Biotech). Samples were 
applied onto ceramic strip holders (Pharmacia Biotech), connecting two electrodes, in 
contact with 18 cm polyacrylamide gel strips (pH range: 3-10, Pharmacia Biotech). 
Isoelectrophocusing (lEF) was performed on IPGphor (Pharmacia Biotech) with the 
following protocol:
-rehydration: 30 min at 20°C 
lEF: 18°C 
-SI: step-n-hold 30 V, 10.0 hours 
-S2: step-n-hold 200 V, 1.5 hours 
-S3: gradient 3500 V, 2.5 hours 
-S4: step-n-hold 3500 V, 2.0 hours 
-S5: gradient 8000 V, 1.5 hours 
-S6 : step-n-hold 8000 V, 6.0 hours 
The lEF was stopped after 75000- 90000 V/h. Second dimension electrophoresis runs 
were performed using a Protean II apparatus (Bio-Rad), connected to a cooled 
recirculating bath. After lEF, strips were soaked first for 10 min at room temperature in 
Equilibration buffer (EB: 6  M urea, 3% SDS, 375 mM Tris pH 8 .6 , 30% glycerol) 
containing 2% DTE, then for further 10 min in EB containing 3% iodoacetamide (lAA) 
and traces of bromophenol blue (BBP)r Strips were then applied onto 10% 
polyacrylamide gels in 375 mM Tris pH 8 .8 . The running buffer contained 144 g/1 
glycine, 30 g/1 Tris base, 0.5% SDS. Gels were run in the same apparatus at 90 V for 
about 13 hours, until BBP was near the bottom of the gel. Proteins were then transferred 
onto nitrocellulose membranes (Schleicher & Schuell) using a tank blot system (Hoefer) 
in 25 mM Tris pH 7.5, 0.192 M glycine, 20% methanol. Western blots were performed 
as described in the previous paragraph.
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2.6 E, coli strains
DH5a: Strain with genotype supE44 DlacUl69 (F80 lacZDM15) hsdRl 7 recAl 
end A1 gyrA96 thi-1 relAl. A recombinant-deficient suppressing strain used for plating 
and growth of plasmids.
XL 1-Blue: Strain with genotype supE44 hsdRl? recAl endAl gyrA46 thi relAl 
lac~ F'(proAB^lacNlacZDM15TnlO(tef)). A recombination-deficient strain that will 
support the growth of vectors carrying some amber mutations. Transfected DNA is 
modified but not restricted. The F' in this strain allows blue/white screening on X-GAL 
and permits bacteriophage M l3 superinfection.
HBlOl: supE44 hsdS20(rB~niB~) recA13 ara-14proA2 lacYl galK2 rpsL20xyl-5 
mtl-L A suppressing strain commonly used for large-scale production of plasmids. It is 
an E. coli K12 X & coli B hybrid that is highly transformable.
BL21M: Strain with genotype hsdS gal (X clts857ind 1 Sam? nin5 lacUV5-T? 
genel). A strain used to express at high levels genes under the control of T7 promoter. 
It lacks the plasmid pLysE, coding for T7 phage lysozyme which inhibits the RNA 
polymerase basal activity.
E. coli bacteria were generally grown in LB (Luria-Bertani) Medium supplemented with 
ampicillin at a concentration of 100 mg/ml or kanamycin at a concentration of 25 mg/ml 
as selective agents.
LB (per litre): 
bacto-tryptone lOg
bacto-yeast extract 5g 
NaCl lOg
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To express recombinant HMGBl, bacteria were grown in M9 minimal medium:
M9 (per litre): 
5 X M9 salts 
1 M MgS04 
1 M CaCl2
2 0 0  ml 
2  ml 
0.1%
5 X M9 salts (per litre): 
Na2HP04 • 7 H2O 64 g 
KH2PO4 15 g
NaCl 2.5 g
NH4CI 5 g
2.7 Protocol of plasmid DNA extraction
Plasmid DNA was prepared using two classical techniques of plasmid extraction. The 
first was used to prepare plasmid DNA from 3 ml of many different cultures (1 to 24) of 
plasmid-containing bacteria (Maniatis, 1989). The second one was used to isolate large 
quantities of plasmid DNA, using anionic exchange cartridges produced by QIAGEN. 
Bacterial cells were lysed under alkaline conditions and the crude lysates were cleared 
by centrifugation. The cleared lysate was then loaded onto the anion-exchange tip where 
plasmid DNA selectively binds under appropriate low-salt and pH conditions. RNA, 
proteins, metabolites, and other low-molecular-weight impurities were removed by a 
medium-salt wash, and plasmid DNA was then eluted in high-salt buffer. The DNA was 
concentrated and desalted by isopropanol precipitation and collected by centrifugation.
2.8 Plasmid and constructs
The plasmid pEGFP-HMGBl contains the open reading frame of HMGB 1 fused 
at the 3' end with the coding region of the Enhanced Green Fluorescent Protein
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(Enhanced GFP). It was generated by inserting a 680 bp fragment of rat HMGBl cDNA 
(35bp upstream the ATG until the stop codon) into the pEGFP-Nl vector (Clontecb) 
using the EcoRI and SacII restriction sites. Both restriction sites were inserted at the 
ends of the cDNA by PGR, using the following oligonucleotides:
£coR I
HMGBl-EcoRI for 5’ - AGGAATTCCGGTGCCTCGCGGAG - 3’
Sac II
3’ HMGBl-GFP rev 5’ - ACCCCGCGGTTCATCATCATCATC - 3’
The plasmids pEGFP-Hlc (a gift from A. Gunjan), pEGFP-HMGN2 (a gift from R. 
Hock and M. Bustin) and pEGFP-NFl (a gift from N. Bbattacbaryya) encode GFP 
fusions to the chromatin proteins bistone Hlc and HMGN2, and to the general 
transcription factor N Fl.
The plasmid pEF-ftag-mlCAD (a gift from S. Nagata) is a mammalian expression 
vector of mouse ICAD-L, tagged at the N-terminus with the Flag epitope.
The pSGD9 construct was kindly provided by V. Zappavigna, and contains the 
human H0XD9 gene cloned in the SV40 early-promoter-based mammalian expression 
vector pSG5 (Zappavigna et al., 1996). The pTSlHCR reporter construct contains a 
single copy of the H0XD9 100 bp autoregulatory element HCR, cloned into the 
polylinker of the pTSlluc luciferase reporter vector (Zappavigna et al., 1996). PRLnull 
carries the Renilla luciferase coding region with no minimal promoter, and was used as 
internal control of the transfections.
The plasmid pT7-7-rHMGlcm, encoding the full-length HMGBl protein, was a 
kind gift of Prof. J.O. Thomas (Cambridge).
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2.9 Transient and stable transfections
HeLa cells were transfected by calcium pbospbate co-precipitation. To express 
HMGBl-GFP, 200,000 cells were plated in 6  cm disbes and were transiently transfected 
witb 8 pg of pEGFP-HMGBl. Cells were observed 24-48 bours after transfection. Tbe 
average amount of HMGBl-GFP in tbe cell population was between 1 and 3% of 
HMGBl (as measured by immunoblotting witb anti-HMGBl antibodies). At tbe single 
cell level, tbe amount of HMGBl-GFP varied at most tenfold between different cells; 
care was always taken to use for analysis only cells witb a moderate fluorescence level.
In tbe H0XD9 transfection assay, 200,000 cells were transfected witb 1.5 pg of 
reporter plasmid (pTHCR), 1 pg of pSGD9, increasing amounts (0-2 pg) of constructs 
expressing HMGBl or HMGBl-GFP (pHMGBl or pEGFP-HMGBl) and 300 ng of 
pRLnull as an internal control. Transfection was carried out in triplicate batches. Forty 
eight bours after transfection, cells were harvested and luciferase activities were 
measured using tbe Dual-Luciferase reporter assay system (Promega) and Lumino 
luminometer (Stratec).
To generate stable transfectants overexpressing ICAD, ~ 600,000 HeLa cells 
plated in 1 0  cm disbes were co-transfected by calcium pbospbate co-precipitation witb 
20 pg of pEF-flag-mlCAD and 4 pg of tbe plasmid pcDNA3 carrying neomycin 
resistance. Seventy two bours after transfection cells were diluted 1:10 and neomycin 
(Roche) was added to tbe medium to 0.9 mg/ml final concentration. After ten days of 
selection, resistant transformants were picked picked witb sterile tips, trypsinised, 
grown in 10-cm disbes and analysed for ICAD expression by Western blot, witb anti- 
Flag monoclonal antibody (M2, Kodak).
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2.10 Detection of DNA fragmentation inhibition in cells overexpressing ICAD
To check for the inhibition of DNA degradation, cells from three different clones 
forced to undergo apoptosis were stained with TUNEL (Apoptosis detection system, 
Promega), and their chromosomal DNA was extracted and analyzed by electrophoresis 
on agarose gels.
TUNEL staining measures the fragmented DNA of apoptotic cells by catalytically 
incorporating fluorescein-12-dUTP at 3'OH DNA ends using the enzyme terminal 
deoxynucleotidyl tranferase (TdT), which forms a polymeric tail (TUNEL assay: TdT- 
mediated dUTP Nick-End Labelling). Wt and stable transfected cells treated with TNF- 
a  and cycloheximide were permeabilised as described in paragraph 4.2, fixed with 4% 
methanol-free formaldehyde, incubated for 10 min with equilibration buffer (200 mM 
potassium cacodylate pH 6 .6 , 25 mM Tris-HCl pH 6 .6 , 0.2 mM DTT, 0.25 mg/ml BSA, 
and 2.5 mM cobalt chloride) and then incubated at 37°C for 1 hour with 50 pi of a 
solution containing 45 pi of equilibration buffer, 5 pi of nucleotide mix (50 pM 
fluorescein-12-dUTP, 100 pM dATP, 10 mM Tris-HCl pH 7.6, and 1 mM EDTA), and 
25 units of TdT enzyme. Cells were then washed three times with 2X SSC and once 
with PBS. Slides were finally mounted with Vectashield containing 1.5 pg/ml DAPI, 
and analysed at the fluorescence microscope, using a FITC filter.
To analyse genomic DNA by gel electrophoresis, ~ 500,000 apoptotic cells, from 
three different clones overexpressing ICAD and a control population of wt HeLa cells, 
were recovered, washed with PBS, resuspended in 350 pi Lysis buffer (100 mM Tris 
pH 8.5, 5 mM EDTA, 0.2% SDS, 200 mM NaCl) containing 500 pg/ml proteinase K 
and incubated for 4 hours at 56°C. Proteins were removed by double extraction with 
phenol:cloroform:isoamyl alcohol (25:24:1). DNA was precipitated with 2.5 vol of
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100% EtOH and 300 mM Na-acetate pH 5.3, washed with 70% EtOH, resuspended in 
30 pi of water, and analysed by electrophoresis on a 1.5% agarose gel.
2.11 In vivo microscopy and photobleaching analysis
Living cells expressing HMGBl-GFP were imaged on an Axiovert 135 M 
microscope (Zeiss), by differential interference contrast (DIG) and in fluorescence 
imaging.
Photobleaching experiments were performed on a Leica TCS-SP confocal 
microscope using the 488 nm laser line of an Ar laser (20 mW nominal output, beam 
width at specimen 0.2 pm, detection 500-575 nm). All experiments were done at 37°C. 
For Fluorescence Recovery After Photobleaching (FRAP) experiments, five single 
scans were acquired, followed by a single bleach pulse of 200-500 ms using a spot 
1 pm in radius without scanning. Single section images were then collected at 1.6 s 
intervals. For imaging, the laser power was attenuated to 1% of the bleach intensity. For 
Fluorescence Loss In Photobleaching (FLIP) experiments, cells were repeatedly imaged 
and bleached at intervals of 6  s. Bleaching and imaging settings were identical to the 
ones used in FRAP.
FRAP and FLIP curves were generated from background subtracted images. For 
FRAP, the total cellular fluorescence was determined for each image and compared 
with the initial total fluorescence to determine the amount of signal lost during the 
bleach pulse and during imaging. Typically 10% of total fluorescence was lost during 
the bleach pulse and less than 5% of fluorescence was lost during the entire imaging 
phase. The fluorescence signal measured in a region of interest normalized to the
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change in total fluorescence was determined as
To It
Ir e l =
Tt Iq
where To is total cellular intensity during prebleach, Tt the total cellular intensity at time 
point t, lo the average intensity in the region of interest during pre-bleach, h  the average 
intensity in the region of interest in time point t. This expression accounts for the small 
loss in total intensity caused by the bleach itself and yields a more accurate estimate of 
the immobile fraction. The relative intensity in the bleached region was plotted as 
function of the recovery time. For FLIP, the relative intensity of fluorescence (h  / lo) 
was measured in different areas of the cell, distant from the bleached region, and the 
mean values were plotted as a function of time. Recovery and loss of fluorescence 
curves for each protein were generated on the basis of several measurements from at 
least ten different cells, showing moderate fluorescence levels.
2.12 Binding of recombinant HMGBl to chromatin
Hmgbl'^~  fibroblasts were treated with 2 ng/ml hTNF-a and 35 pM 
cycloheximide. After 16 h, apoptotic cells were recovered by gentle flushing of the dish.
Ten million apoptotic Hmgbl~^~ fibroblasts and a control population of non-apoptotic 
ones were resuspended in 50 pi PBS containing 0.32 M sucrose, 0.5% NP-40 and 1 pM 
bacterially produced HMGBl, either fluorescently labelled with Cy5 (Cy5 mono­
reactive Dye Pack, Pharmacia) or unlabelled. Average labelling was 2.3 Cy5 molecules 
per HMGBl molecule. After 30 minutes at room temperature, apoptotic and non- 
apoptotic cells incubated with Cy5-HMGBl were mixed and mounted on slides using
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Vectashield containing 1.5 pg/ml DAPI, and observed on an Axiophot microscope (Cari 
Zeiss) with rhodamine filter. The two pools of cells incubated with unlabelled HMGBl 
were layered onto discontinuous gradients, formed by 5 ml of 1.16 M sucrose in PBS 
and a 6  ml cushion of 2 M sucrose in PBS. The gradients were centrifuged at 30,000 x g 
for 90 minutes in a SW27 Beckman rotor. Apoptotic and non-apoptotic chromatin free 
from membrane debris was recovered from the bottom of the tubes, dissolved in SDS- 
PAGE loading buffer and electrophoresed through a 12% SDS-PA gel. The amount of 
recombinant HMGBl bound to apoptotic and non-apoptotic chromatin was detected by 
Western blot. Aliquots of apoptotic and non-apoptotic chromatin were also probed with 
various antibodies: anti-acetyl-histone H4 (RIO, a gift from B. Turner), anti-acetyl- 
Histone H3 (Lys 9, Biolabs) and anti-acetyl-lysine antibody (Biolabs) to check the 
acétylation status of core histones.
2.13 Bone marrow extraction and stimulation by necrotic and apoptotic cells
Thighbones from the hind legs of female C56B16 mice were recovered and cut at 
both ends. Bone marrow cells were obtained by flushing with 1.5 ml of PBS using a 1 
ml syringe. After centrifugation at 1200 rpm for 5 min, cells were diluted to 5 x 10^  
cells/ml in Optimem (Gibco), dispensed in 96-well plates (120 pi per well) and left to 
attach for three hours before stimulation.
Necrotic wt and HmgbH' fibroblasts were obtained by 3 cycles of freeze-thawing 
in liquid nitrogen. Living cells were trypsinised and resuspended in PBS to a final 
concentration of 25.000 cells/pl prior to lysis. Apoptotic cells, obtained by TNF- 
a/cycloheximide treatment, detached from the plate, were recovered and washed twice 
in PBS. Necrotic and apoptotic cells were added to increasing final concentrations into
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the wells containing bone marrow cells and incubated at 37°C for 18 hours. TNF-a 
released in the supernatant was assayed by ELISA (Quantikine M, R&D Systems).
2.14 Induction of liver necrosis by acetaminophen overdose
One day old mice (weighing 1.1+ 0.1 grams) were injected intraperitoneally with 
20 pi of PBS containing 320 pg of acetaminophen (Sigma), and 320 pg of antibodies 
(either anti-HMGBl, or rabbit IgG form Sigma) where indicated. After 9 hours mice 
were decapitated, blood was collected, and liver was taken. Blood samples were 
allowed to clot overnight at 4° C, sera were recovered and analyzed for alanine 
transaminase (ALT) activity with the GP-Transaminase kit (Sigma). The recruitment of 
inflammatory cells was quantified by assessing the liver myeloperoxidase (MPO) 
content. Liver samples were homogenized in buffer B (43.2 mM KH2HPO4, 6.5 mM 
Na2HP0 4 , 10 mM EDTA, 0.5% hexadecyltrimethylammonium, pH 6.0) (2 ml of buffer 
B per 100 mg of tissue). After heating for 2 hours at 60° C, 6 6  pi of homogenised liver 
were reacted with 133 pi of 3,3’,3,5’-tetramethylbenzidine (Sigma) for 8 min. Samples 
were then centrifuged for 3 minutes at 13,000 rpm, and the optical density of the 
supernatant was determined at 655 nm (Kato et al., 2000)
Statistical analysis was performed with the non-parametric Mann-Whitney test 
on MPO/ALT ratios, using Prism software.
2.15 Purification of recombinant HMGBl (by Tiziana Bonaldi)
A colony of BL21(-) freshly transformed with the plasmid pT7-7-rHMGlcm was 
used to inoculate an overnight culture grown in M9 medium complemented with 20 g/1 
cas-aminoacids, 0.5% glycerol, 5 g/1 yeast extract, 0.4% glucose and 100 pg/ml
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chloramphenicol. The overnight culture (300 ml) was then used to inoculate a 3 1 
culture in an ADI 7 1 autoclavable bioreactor (Applikon). At an optical density OD595 
of 0.7, IPTG was added to the culture to a final concentration of 0.5 mM. Shaking was 
reduced to 150-200 rpm and temperature to 23°C. Growth was continued for another 16 
hours. Cells were centrifuged in GSA rotor 5 Kpm for 10 min at 4°C, resuspended in 
120 ml of buffer L2 (50 mM Tris-HCl pH 8.0, 20 mM EDTA, 1 mM DTT, 0.5 mM 
PMSF) and sonicated with a large piston 6  times for 1 minute. NaCl was added to a 
final concentration of 0.5 M. After 5 min on ice, the suspension was centrifuged at 10 
Kpm 10 min at 4°C. Solid (NH^)2S0  ^ (3.9 g) was added for every 10 ml (final 60% 
solubility). After 30 min on ice, the solution was centrifuged at 10 Kpm for 10 min in a 
SS-34 rotor at 4°C. The supernatant was loaded on a Phenyl-Sepharose Pharmacia 
column connected to a FPLC system; the protein was eluted with stepwise decreasing 
elution (60, 50, 40, 30%) in Buffer B (20 mM HEPES pH 7.9, 0.5 mM DTT, 0.2 mM 
PMSF, 0.2 mM EDTA pH 8.0, 60% (NH^)2S0 )^. The positive fractions were collected, 
pooled and dialysed overnight in 500 ml Buffer A' (50 mM Hepes pH 7.9, 0.5 mM 
DTT, 0.2 mM PMSF, 20 mM NaCl). The dialysed sample was loaded on a Hi-trap SP 
column (Pharmacia) and eluted with an increasing ionic-strength buffer (20mM-lM 
NaCl, 20 mM HEPES pH 7.9, 0.5 mM DTT, 0.2 mM PMSF, 0.2 mM EDTA). The 
sample was concentrated with Centricon-10 cartridges (Amicon) and desalted with PD- 
10 columns (Pharmacia), and stored in phosphate buffer pH 7.5, containing 0.5 mM 
DTT, 0.2 mM PMSF, 0.2 mM EDTA.
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3 RESULTS
3.1 Subcellular localisation of HMGBl in living cells
Previous studies have shown that HMGBl binds with high affinity to in vitro 
reconstituted nucleosomes but, contrary to other chromatin binding proteins, is only 
loosely bound to chromatin, and rapidly leaks out into the medium when cellular 
membranes are permeabilised (Falciola et al., 1994). This observation was interesting 
but puzzling: I therefore decided to gain insight into this issue and better characterize 
the chromatin binding properties of HMGBl within the cell.
In order to analyse the behaviour of the protein in living, unperturbed cells, I 
employed non-invasive techniques, based on the Green Fluorescent Protein (GFP).
3.1.1 The GFP technology
The use of the GFP in cellular and molecular biology has given an extraordinary 
contribution towards the understanding of how events occur inside of living cells.
GFP is a protein of the jellyfish Aequorea victoria, and is responsible for the green 
lining along the margins of the jellyfish’s bell. GFP is unique among light-emitting 
proteins in that it does not require the presence of any cofactors or substrates for the 
generation of its green light. In the jellyfish, GFP is activated in a Ca-dependent manner 
by another bioluminescent protein, aquorin, which transfers energy indirectly to GFP to 
trigger the release of green light (Prasher, 1995). This energy transfer can be mimicked 
experimentally by simple exposure of GFP to standard long-wave ultraviolet (UV) light.
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The crystal structure of GFP has been solved and shown to be a remarkable 
barrel-like arrangement (Ormo et al. 1996): eleven p-sheets surround a central a-helix, 
containing the fluorescent centre, which is formed by a hexapeptide (Fig. 9). The 
chromophore itself is formed by a Ser65-Tyr66-Gly67 tripeptide, which forms in an as- 
yet uncharacterised cyclization process in the presence of oxygen (Heim et al., 1994). 
Mutational analysis of this and other regions of the protein have produced “improved” 
GFP isoforms, brighter and more resistant to photobleaching (Heim and Tsien, 1996).
GFP is already an invaluable tool to monitor protein localisation in living cells 
and to visualize dynamic cellular events. A fusion between any cloned gene of interest 
and GFP can be produced by standard subcloning techniques and may be introduced 
into the organism of interest by transient or stable expression. The fate of the resulting 
protein inside the living cells can be followed by conventional fluorescence microscopy. 
Importantly, detection does not require fixation or permeabilisation of cells; therefore, 
compared with immunocytochemistry techniques using fixed cells, the likelihood of 
artifacts is reduced. On the other hand, the addition of relatively large GFP-tag of 27 
KDa can affect the functionality of the fused protein of interest. It is therefore necessary 
that each fusion protein be carefully tested for its functionality in vivo.
gas Fig. 9 Three-dimensional structure of GFP. Ribbon 
diagram of the Green Fluorescent Protein (GFP) drawn 
from the wild-type crystal structure. The buried 
chromophore, which is responsible for GFP's 
luminescence, is shown in full atomic detail.
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3.1.2 Generation and expression of HMGBl-GFP in HeLa cells
I generated a chimeric protein in which the Green Fluorescent Protein is fused to 
the C-terminus of HMGBl (Fig. 10).
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Fig. 10 Plasmid encoding GFP- 
HMGBl. The HMGB1 coding region 
is fused to the GFP open reading 
frame, in the mammalian expression 
vector pEGFP-Nl (Clontech). Cell 
transfected with the plasmid express 
HMGBl fluorescently labelled by the 
c-terminal GFP.
The coding sequence of HMGBl was inserted upstream the 5’ end of the GFP open 
reading frame. We employed for our studies the enhanced version of GFP, which 
incorporates silent base mutations corresponding to human codon-usage preferences 
and allows a higher expression in mammalian systems. Enhanced GFP (EGFP) also 
includes chromophore mutations which increase its fluorescent intensity and make it 
less susceptible to photobleaching.
In order to study the subcellular localisation of HMGBl in living cells, HeLa cells 
were transfected with pEGFP-HMGBl and analysed on an inverted microscope. In 
interphase, HMGBl-GFP was entirely localised in the nucleus of the cells, showing a 
uniform, finely punctate distribution in the whole nucleoplasm, with a less intense
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staining on nucleoli (Fig. 11 A) An identical pattern of staining is obtained by detecting 
endogenous HMGBl in fixed cells by indirect immunofluorescence (Fig. IIB).
GFP-HMGB1
HMGBl
Fig. 11 Subcellular localisation of HMGBl in interphase cells. Scale bars, 7.5 pm.
A. Living HeLa cells e?q)ressmg HMGBl-GFP were imaged by differential interference 
contrast microscopy and in green fluorescence. In living cells, HMGBl-GFP is completely 
localised within the nucleus, showing a lower concentration in the nucleoli.
B. Hela cells were fixed with PFA and stained for HMGBl and DNA. A distribution identical to 
that observed in fiving cells is obtained also in fixed cells by immunodetecting the endogenous 
protein.
Cells undergoing mitosis, instead, showed a low diffuse cytoplasmic 
fluorescence, but also a distinct association of HMGBl-GFP to condensed 
chromosomes, lasting throughout M phase (Fig. 12A). This observation was unexpected 
since no HMGBl bound to mitotic chromosomes can be detected in fixed cells by
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immunofluorescence (Fig. 12B), and the protein appears totally displaced from 
condensed chromatin.
anaphase
metaphase
H M G B1
Fig. 12 Subcellular localisation of HMGBl in mitotic cells. Scale bars, 6 pm.
A. In living cells, during mitosis HMGBl-GFP is distributed in the whole cell but is highly 
concentrated onto condensed chromosomes
B. An opposite distribution is observed in fixed cells, by immunodetecting the endogenous 
HMGBl: the protein is displaced from chromosomes and accumulates in the cytoplasm.
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I investigated the cause of the discrepancy between data obtained in living and 
fixed cells and found that fixation abolishes the association of HMGBl with 
chromosomes. When HMGBl-GFP expressing cells are fixed, with paraformaldehyde, 
acetone, and/or acetic acid, an immediate loss of fluorescence from the chromosomes is 
observed. This is not due to specific fluorescence quenching within the chromosomes, 
as indirect immunofluorescence with anti-GFP antibodies confirmed the loss of the 
association of the fusion protein to the chromosomes (Fig. 13).
We concluded that in living cells HMGBl is bound to the condensed chromatin, 
but this association is not stable and is rapidly lost upon cell manipulation.
anti-GFPHMGBl-GFP
Fig. 13 Effect of fixation on the binding of HMGBl to chromatin. HeLa cells expressing 
HMGBl-GFP were fixed with 4% PFA. Indirect immunofluorescence was performed using an 
anti-GFP antibody and a TRITC-coniugated secondary antibody, and DNA was stained with 
DAPI. Following fixation, HMGBl-GFP is detached from chromosomes. Scale bar, 6 pm.
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3.2 Functionality of HMGBl-GFP
In order to check the functionality of the chimeric protein, I compared HMGBl- 
GFP with the unmodified HMGB 1 in its ability to enhance the expression of a H0XD9- 
responsive reporter gene in transfection assays. HMGBl is one of the co-factors 
cooperating with HOX proteins in the recognition of their specific target sequence. 
HMGBl and H0XD9 establish protein-protein contacts via their HMG-boxes and 
homeodomain, respectively, and in transient transfection assays, co-expression of 
HMGB 1 and H0XD9 enhances up to 4-fold the transcriptional activation of a reporter 
gene carrying H0XD9 target sequence (HCR) (Zappavigna et al., 1996). In this assay, I 
used as a reporter plasmid, pTHCR, where the HCR element is fused to the herpes 
simplex virus thymidine kinase (TK) promoter, upstream the luciferase coding region. 
HeLa cells were transiently co-transfected with fixed amounts of pTHCR and the 
H0XD9 expression construct pSGD9, and increasing amounts of either pEGFP- 
HMGBl or pHMGBl, which contains the whole Hmgbl gene under the control of its 
own promoter (See Materials and Methods). pEGFP-HMGB 1 was able to stimulate the 
H0XD9-mediated transcription in a way comparable to pHMGBl (Fig. 14), showing 
that the presence of the fused GFP does not impair the transactivational activity of 
HMGBl
p S G D 9 -f
pHMGBt  pEGFP-  
HMGB1
Fig. 14 The fusion to GFP does not Impair the 
transactivational activity of HMGBl. HeLa cells 
were transfected with fixed amounts of the reporter 
plasmid pTHCR and pSGD9, and increasing 
amounts of either pHMGBl or pEGFP-HMGBl. 
Both HMGB I and HMGBl-GFP enhance HOXD9 
transcriptional activity in transient co-transfection 
assays.
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3.3 Binding of HMGBl-GFP to chromatin in living cells
I then verified whether HMGBl-GFP behaves like endogenous HMGBl upon cell 
permeabilisation. HMGBl-GFP expressing cells, observed on an inverted microscope, 
were treated with 0.15% Triton X-100 or NP-40, and sequential images were collected 
(Fig. 15). Already 4 seconds after the addition of detergents, HMGBl-GFP started to 
diffuse out of the cells, both in mitosis and in interphase, and after 80 seconds cells 
were completely devoid of fluorescent protein. Thus, HMGBl-GFP, like endogenous 
HMGBl, is only loosely associated with chromatin in living cells, and if membranes are 
permeabilised, all the protein leaks out of the cell.
Z- C ' a
Fig. 15 Leakage of HMGBl-GFP from permeabilised cells. HeLa cells expressing HMGBl- 
GFP were permeabilised with NP-40 directly on the microscope, and sequential images were 
collected before and after detergent addition. Less then 1.5 min are sufficient to lose the entire 
complement of HMGB 1 upon permeabilisation. Scale bar, 12 pm.
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3.4 HMGBl is retained in permeabilised apoptotic cells
Even though most HMGBl-GFP transfected HeLa cells lost their fluorescence a 
few seconds after NP-40 addition, some cells retained a bright fluorescence even after 
minutes (Fig. 16). From the blebbed membranes and the characteristically fragmented 
appearance of their nuclei, the fluorescence-retaining cells appeared to be apoptotic.
Fig. 16 Retention of HMGBl by some permeabilised cells. Not all the cells released 
HMGBl after detergent treatment. Even after minutes, some cells maintained their green 
fluorescent signal. Observed at bright field, these cells (arrows) looked morphologically 
different from the other cells, and appeared to be apoptotic. Scale bar, 15 pm.
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To test directly whether HMGBl was specifically retained by apoptotic cells, I 
forced HeLa cells to undergo apoptosis by treatment with Tumor Necrosis Factor-a 
(TNF-a) and cycloheximide, and immunostained them for their endogenous, 
unmodified HMGBL Cells were treated with NP-40 before fixation, and HMGBl was 
detected using an anti-HMGBl antibody. As expected, control non-apoptotic cells 
appeared devoid of HMGBl, which had been released from the nucleus into the 
medium (Fig. 17A). On the contrary, apoptotic cells, recognizable by their condensed 
and fragmented chromatin, showed an intense staining for HMGBl, suggesting that all 
the protein had been retained within the nucleus even after membrane solubilisation 
(Fig. 17B).
The retention of HMGB 1 by permeabilised apoptotic cells was also revealed by 
Western blotting. After NP-40 treatment, soluble proteins released from the nucleus 
were separated from histones and chromatin-associated proteins by centrifugation. In 
control cells, HMGBl leaked completely into the supernatant (Fig. 17A); in contrast, 
with apoptotic cells, the majority of the protein was found in the pellet, associated with 
histones, suggesting that in apoptosis the binding of HMGB 1 to chromatin was more 
stable (Fig. 17B).
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Fig. 17 Chromatin association of HMGBl in permeabilised living and apoptotic HeLa 
cells. The medium bathing the cells (S) was electrophoresed alongside with the cells dissolved 
in loading buffer (P). Histones were visualized by Coomassie staining, HMGBl by 
immunoblotting. Scale bars, 7.5 pm. A. Interphase cells were permeabilised with 0.1% NP-40, 
fixed with PFA, and stained with DAPI and anti-HMGB 1 antibodies. The nucleus was devoid 
of HMGB 1 and most of the protein was found in the medium. B. HMGBl was firmly bound to 
the chromatin of apoptotic cells (recognizable by the their fragmented nuclei), even after NP-40 
permeabilisation; the apoptotic nuclei showed an intense staining, and most HMGBl was found 
associated to the hisones.
This behaviour appeared to be a specific feature of HMGB 1, and not a general 
phenomenon affecting all the proteins in apoptosis. PCNA (Proliferating Cells Nuclear 
Antigens), for example, a DNA binding protein involved in DNA repair, is also 
sensitive to detergents, unless DNA damage is induced; permeabilised apoptotic cells 
however released the protein not unlike living cells (Fig. 18 A). Identical results were
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observed for HMGBl also using different apoptotic stimuli, such as etoposide or H2O2, 
and even in cells spontaneously undergoing apoptosis in unperturbed cultures, HMGB 1 
was not sensitive to permeabilisation. In the same conditions, HMGBl-GFP behaved 
like the endogenous protein, contrary to control unfused GFP, which was always 
released upon NP-40 treatment (Fig.18 B).
+ NP-40
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Fig. 18 Apoptotic cells retain specifically HMGBl. Scale bars, 10 pm.
A. Immunofluorescence on TNF-a-treated HeLa cells. Cells were permeabilised with NP-40, 
fixed and immunostained for DNA and PCNA. Apoptotic cells released PCNA and appeared 
devoid of the protein as well as non-apoptotic cells.
B. Cells expressing unfused GFP were permeabilised with NP-40 while imaged on the 
microscope. Already 30 seconds after detergent addition all the cells lost GFP, including cells 
spontaneously undergone apoptosis (arrows).
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The permeabilisation of apoptotic cells mimics what happens in the latest stage 
of the apoptotic process, when cells undergo partial autolysis and lose their membrane 
integrity even in the absence of detergents. I checked the behaviour of HMGB 1 in this 
condition, prolonging the incubation of apoptotic cells for three days. Already 24 hours 
after apoptosis induction, soluble cytoplasmic proteins like lactate dehydrogenase 
(LDH) started to leak into the extracellular medium, and after 64 hours the entire 
complement of the protein was released. In contrast, HMGBl was mostly retained 
associated with nuclear remnants, and in spite of the leaky membranes no significant 
release into the extracellular medium was observed (Fig. 19).
Living Apoptosis Apoptosis Apoptosis Apoptosis 
18 h 24 h 48 h 64 h
HMGB1
LDH
Fig. 19 Kinetics of protein release from cells undergoing apoptosis. Late during apoptosis, 
the integrity of the plasma membrane is lost, and soluble proteins (like lactate dehydrogenase, 
LDH) are leaked out to the medium (S). Even under conditions of extensive LDH leakage, most 
HMGBl is retained associated to the cell remnants (P).
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3.5 Necrotic cells release HMGBl
Since HMGBl appeared to be tightly bound to the chromatin of cells undergoing 
programmed death, I analysed what happens in the case of unprogrammed cell death. 
Whereas apoptosis is an active process where a cell “decides” to suicide, necrosis 
occurs upon mechanical cell damage, trauma or poisoning. Necrosis differs from 
apoptosis biochemically, as it is a passive process where no protein is newly synthesised 
or modified, and morphologically: cells become rich with swollen and empty bodies 
containing disrupted organelles, nuclear chromatin is dispersed, and the integrity of the 
plasma membrane breaks down, making all the soluble proteins leak into the 
extracellular medium.
We forced HeLa cells into necrosis by ATP depletion, treating them with 
combinations of ionomycin and the mitochondria uncoupler CCCP, or deoxyglucose 
and azide. The number of cells undergoing necrosis was scored morphologically, and 
when it approached 50%, the supernatant was collected. A fraction of the treated cells 
was fixed and immunostained for HMGBl, the rest was analysed by Western blot, 
alongside with the extracellular medium. No HMGBl was found associated with the 
remnants of necrotic cells, and a significant amount of the protein was recovered in the 
medium without any need for treatment with detergents (Fig. 20). Thus, as soon as the 
plasma membrane of the necrotic cells loses its integrity, HMGBl diffuses out of the 
nucleus, and leaks into the extracellular medium.
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Fig. 20 Chromatin association of HMGBl in necrotic HeLa cells. HMGBl was not 
associated to the chromatin of necrotic cells, even in absence of NP-40 permeabilisation. The 
amount of HMGB 1 recovered in the medium was proportional to the number of necrotic cells 
(about 50%). Scale bars, 6 pm.
Taking together, the data obtained on apoptotic and necrotic cells lead to the 
conclusion that, upon cell death, HMGB 1 behaves in opposite ways depending on how 
the cell dies. When sudden and unprogrammed death occurs, HMGBl is passively 
released out of the cells, whereas in case of programmed cell death HMGBl is firmly 
retained in the nucleus, even after autolysis of the cell.
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3.6 Mobility of HMGBl within the nuclei of living cells
The first set of experiments indicated that HMGBl has three states of association
with chromatin in living and dead cells: loose binding in living cells (both interphase 
and mitotic), no binding in necrotic cells, and tight binding in apoptotic cells.
In living interphase cells, at least a fraction of HMGB 1 must bind to DNA, as we
can detect the biological effects of this binding, for instance in terms of enhanced
transcription. Nevertheless, this association is not stable and even upon detergent 
extraction we cannot distinguish between the soluble and the chromatin-associated 
pools. In mitosis, however, there is a clear spatial distinction between chromatin and 
cytoplasm, and in this condition it is evident that the majority of HMGB 1 is bound to 
the chromosomes, and only a smaller fraction diffuses in the cytoplasm. This 
incomplete chromatin association in living cells could be due to the existence of two 
different HMGBl pools, or a fast equilibrium of a single pool between two states. To 
discriminate between these possibilities, I probed the dynamic properties of HMGBl- 
GFP within mammalian nuclei with photobleaching techniques.
3.6.1 Photobleaching analysis
Photobleaching techniques are non-invasive microscopy methods which reveal 
the dynamics underlying the steady-state distribution of a fluorescently tagged protein 
in living cells. A fluorophore within a small region is irreversibly destroyed with a high 
intensity laser pulse. After bleaching, the labelled protein is photochemically altered, so 
that it no longer fluoresces, but otherwise retains completely its biological activity 
(Tsien, 1995). The exchange between the bleached and unbleached populations of 
fluorophore is then monitored, and used as an indicator of the overall mobility of the
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protein. Two commonly used variations of this analysis, yielding complementary types 
of information, are fluorescence recovery after photobleaching (FRAP) and 
fluorescence loss in photobleaching (FLIP).
In FRAP, a small area in a cell expressing the fluorescent protein of interest is 
bleached once using a short laser pulse. Bleaching generates a region devoid of 
fluorescence signal, but if the molecule moves within the cell, the influx of unbleached 
molecules into the bleached area leads to a progressive recovery of fluorescence. The 
recovery kinetics depends on the exchange of molecules in the bleached region, and 
thus can be used to quantify the mobility of the protein (Fig. 21A).
In FLIP, a region of interest is repeatedly bleached, and the loss of fluorescence 
from outside the bleached region is monitored, by imaging after each bleach dose. FLIP 
studies are particularly useful when the protein is not uniformly distributed but 
concentrated in defined intracellular sites, because it allows flux between populations of 
the fluorophore localised in different regions to be studied. In this case, the bleaching is 
made in the vicinity of the structure where the protein is concentrated. This creates a 
favourable situation for assessing the departure kinetics of molecules from that site into 
the surrounding zone in which they prevail at a lower steady state concentration, and 
this is observed as a loss of fluorescence from the region adjacent to the bleached spot 
(Fig. 21B).
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Fig. 21 In vivo photobleaching techniques: FRAP and FLIP. Scale bars, 2.5 pm.
A. In fluorescence recovery after photobleaching (FRAP), the fluorescence intensity in a small 
area after bleaching by a short laser pulse is measured using time-lapse microscopy. The 
recovery kinetics of mobile molecules are dependent on the mobility of the proteins. Immobile 
proteins show no recovery. Example of FRAP analysis performed on HeLa cells expressing a 
GFP-ftision to histone HI. In the bleached spot the fluorescent signal is lost after the laser pulse, 
but it is progressively recovered, thanks to the movement of the protein.
B. In fluorescence loss in photobleaching (FLIP), the fluorescence intensity is measured m a 
small area after repeated bleaching of a region that is distant from this area. The rate of loss of 
fluorescence signal is dependent on the mobility of the protein. Immobile proteins show no 
loss. Example of FLIP analysis performed on HeLa cells expressing GFP-fiision to the 
transcription factor NFl. After repeated bleaching of a small spot, the fluorescence signal is lost 
also outside that region, until all the fluorescence in the nucleus is exhausted.
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The recovery of fluorescence in FRAP and the loss of fluorescence in FLIP are 
measured as a function of time using time-lapse microscopy, generating graphs like 
those shown in Fig. 22, which allow different biophysical parameters of the labelled 
molecule to be estimated. From FRAP curves we can easily determine the mobile and 
immobile fractions of the protein: the mobile fraction is the proportion of fluorescence 
that is regained, whereas the difference between the initial and final fluorescence 
corresponds to the immobile fraction. The recovery curve also gives a rough indication 
of the maximal time spent by the molecule in the same site before moving away 
(maximal residence time), which corresponds to the time when the recovery curve 
reaches the plateau. An additional parameter easily estimable by means of FRAP 
analysis is the diffusion coefficient of the protein, which allows to quantify the effective 
speed of the molecule. On the other hand, the rate of loss of fluorescence in FLIP 
experiments contains information on the dissociating flux of the protein from a 
particular site, and in combination with kinetic modelling allows the determination of 
relative rate constants for association and dissociation from compartments (Phair and 
Misteli, 2001).
FRAP and FLIP experiments measure apparent, not absolute, mobility, which is a 
combination of the diffusional mobility and the specific biological properties of a 
protein. In case of energy-independent transport, the most important factor which 
affects the speed of a molecule is the network of interactions established with cellular 
components which are relatively more immobile, such as cytoskeleton, membranes or 
chromatin. For chromatin binding proteins, the overall mobility is determined by their 
chromatin binding properties, therefore photobleaching methods can be used as a 
quantitative assay for their binding to chromatin in vivo.
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Fig. 22 Quantitative analysis from FRAP and FLIP.
A. An idealized plot of fluorescence intensity (1) as a function of time shows the parameters of a 
quantitative FRAP experiment. The bleach region is monitored during a pre-bleach period to 
determine the initial intensity f. This region is bleached using high-intensity illumination 
(intensity is not plotted during the bleach), and recovery is monitored immediately after the 
bleaching, until I reaches a final value If, when no further increase can be detected. Some 
methods calculate the effective diffusion coefficient, De% directly from the time to reach half 
final intensity; the mobile fraction and the maximal residence time of the protein can also be 
measured. To determine all the parameters as accurately as possible, I must be corrected for the 
background intensity, and the amount of total fluorescence removed by the bleach.
B. An idealized plot of fluorescence intensity (I) as a function of time shows the parameters of a 
quantitative FLIP experiment. A region distant from the bleached area is monitored during a 
pre-bleach period to determine the initial intensity h and after each round of bleaching. The loss 
of fluorescence is monitored until I reaches a final value, when no further decrease can be 
detected. In combination with computational modelling the kinetics of loss of fluorescence 
allow the quantitation of biophysical properties of molecules and processes.
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3.6.2 FRAP analysis on HMGBl in living cells
I performed FRAP analysis on HeLa cells expressing HMGBl-GPP. A high- 
powered laser pulse of 250 ms was pointed in nucleoplasmic spots of transiently 
transfected cells and recovery of fluorescence was monitored starting 1 .6  seconds after 
the laser pulse. Unexpectedly, after the bleaching, a minimal loss of HMGBl-GFP was 
observed in the selected areas, detectable only by pixel analysis, and the total 
fluorescence in the entire nucleus appeared slightly reduced (Fig. 23A,C). This result 
can only be explained by the rapid exchange of bleached protein in the target spot with 
unbleached protein from the surrounding areas, which recovers most of the fluorescence 
before the first image collection. Indeed, if the same experiment is done in 
paraformaldehyde-fixed cells in order to block the protein movement, a clear dark spot 
appears after the bleaching, and no recovery at all is observed, confirming that the 
minimal loss of fluorescence in living cells is due to the rapid movement of HMGBl- 
GFP(Fig.23B,C).
The quantitative analysis shows that in living cells 80% of the fluorescent signal 
is already regained after 1.6  seconds, and the recovery is essentially complete after 4 
seconds (Fig. 23C). This value corresponds to the maximal residence time of HMGBl 
on chromatin, and gives a clear idea of the dynamic behaviour of the protein in the 
nucleus. This rapid movement is energy-independent, as inhibition of ATP synthesis did 
not affect the kinetics of the process.
The mobility of HMGBl-GFP appeared to be much faster than that of other 
nuclear proteins used as controls (Fig. 23 D). HMGNl-2 are closely related chromatin 
proteins belonging to the HMGN subclass of the high mobility protein family, different 
from the HMGB one (Bustin et al., 1990; Bustin, 2001). They bind to nucleosomes and 
are thought to alter the higher order chromatin structure, modulating the access of
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transcriptional regulators to DNA. Confirming published data (Phair and Misteli, 2000), 
I found that also HMGN 1-2 are highly mobile in the nucleus, but the maximal residence 
time of these proteins is about 8 fold longer compared to HMGBl.
I also analysed the mobility of the linker histone HI. HI is also believed to be 
involved in chromatin organisation by stabilising higher order structures, and it has 
been considered for a long time a sort of HMGBl alter ego (Dimitrov et al., 1994, 
1993; Ner and Travers, 1994), with overlapping functions. As mentioned in the 
introduction (paragraph 2.5), previous findings had already argued against this view, 
ruling out the possibility of a shared structural role for HMGBl and histone HI 
(Falciola et al., 1994; Spada et al., 1998). Photobleaching experiments confirmed those 
data. Again in accordance with published results (Misteli et al., 2000; Lever et al., 
2000), I found that also HI-GFP is not static and is continuously exchanged between 
chromatin regions; however the mobility of the protein is extremely low, indicating a 
strong association to DNA. The maximal residence time of HI, about 4 minutes, is 
much longer than the 4 seconds of HMGBl, and suggests completely different 
chromatin binding properties for the two proteins.
Only unfused GFP, which is usually used as a standard in this type of assays, 
appeared to be faster than HMGBl-GFP, recovering its fluorescence signal to 98% of 
the pre-bleach value within 1 s. This result-was expected as unfused GFP does not 
functionally interact with any molecule within the nucleus and its diffusion mobility is 
not slowed at all.
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Fig. 23 HMGBl dynamics in interphase cells: FRAP ananlysis. Scale bars, 2.3 pm.
A. FRAP in living cells. A HeLa cell expressing HMGBl-GFP was imaged before and during 
recovery after a single bleaching of a nuclear area (circle) for 250 ms. Images, shown in 
pseudocolours, were taken at the indicated times after end of the bleach pulse. Most of the 
fluorescence in the bleached spot was recovered already after 1.6 s, indicating a very rapid 
movement of the protein.
B. FRAP in fixed cells. Cells were fixed with PFA and analysed as described in A. When the 
movement of HMGBl-GFP was blocked, no recovery was observed in the bleached spot.
C. Kinetics of fluorescence recovery in FRAP on HMGBl-GFP. In living cells, the 
fluorescence signal was 80% recovered after 1.6 s already, and completely recovered after 4 s. 
In fixed cells, the fluorescence signal decreased to the background level after the bleaching, and, 
afterwards, the recovery curve was completely flat.
D. Kinetics of fluorescence recovery in FRAP on GFP-fiisions to HMGN2, NFl and histone 
HI. The kinetics of fluorescence recovery for all the other nuclear proteins used as controls was 
slower compared to HMGBl-GFP.
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3.6.3 FLIP analysis on HMGBl in living cells
I verified the high mobility of HMGBl also by FLIP analysis. In interphase cells, 
after 2 minutes of repeated bleaching in the same nucleoplasmic spot, the fluorescence 
signal was lost in the entire nucleus confirming that HMGBl-GFP moves very rapidly 
(Fig. 24A). In contrast, fluorescence loss in HeLa cells expressing GFP fusions to 
chromatin proteins HMGNl and HMGN2, transcription factor NFl, or histone HI was 
significantly slower (Fig. 24C).
I extended the analysis to mitotic cells, where HMGBl is mostly associated with 
chromosomes, but also present in the cytoplasm, at a lower concentration. This is the 
ideal situation to study the binding of HMGBl to chromatin, since DNA is clearly 
separated from the cytoplasm, and it is possible to discriminate between soluble or 
DNA-bound molecules. In FLIP experiments, repeated bleaching of cytoplasmic 
HMGBl-GFP led to rapid and complete loss of fluorescence both from condensed 
chromosomes and from the cytoplasm, with comparable kinetics (Fig. 24B,D). This 
result indicates that also in mitosis all HMGBl molecules are highly dynamic and 
rapidly shuttle between the cytoplasm and chromosomes. The concentration of HMGBl 
on chromosomes therefore is not due to a static binding, but rather is the result of a 
steady-state in which HMGBl rapidly and continuously associates and dissociates on 
DNA. In these experiments, the laser was pointed on a cytoplasmic region, thus the loss 
of fluorescence on chromosomes is a measure of the departure flux of HMGBl from 
DNA. This flux depends on both association/dissociation kinetics on DNA and the 
diffusion rate of the molecules. Instead, the loss in the cytoplasm is dependent only on 
the diffusion rate of the protein. The curves obtained in both cases are identical, and this 
implies that the binding of HMGBl to chromosomes does not slow significantly its 
diffusion movement, further confirming the transient nature of this association.
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Fig. 24 HMGBl dynamics in interphase and mitotic cells: FLIP analysis. Scale bars, 2.3 
pm.
A. FLIP on interphase cells. The area indicated by a circle was repeatedly bleached for 200 ms, 
and cells were imaged between bleach pulses. After 2 minutes almost all the fluorescence signal 
was lost from the entire nucleus, showing a high intranuclear mobility of HMGBl-GFP. A 
neighbouring cell nucleus was not affected by the repeated bleach pulses.
B. FLIP on a cytoplasmic region of a mitotic cell. The loss of fluorescence was fast and 
complete in the whole cell, including condensed chromosomes. There is interchange between 
chromosomal and cytoplasmic pools of HMGBl-GFP, and a rapid dissociation of the protein 
from condensed chromatin.
C D. Kinetics of fluorescence loss in FLIP. In interphase cells HMGBl-GFP fluorescence was 
lost much faster than that of other nuclear proteins (C). In mitotic cells, bleaching was executed 
on a spot in the cytoplasm, and quantification was done both on a different spot in the 
cytoplasm, or on a spot on the condensed chromosomes. The kinetics are identical (D), 
indicating a rapid turnover of HMGBl-GFP on condensed chromatin.
78
Photobleaching analysis confirmed the indication derived from detergent 
extraction experiments, proving that in living cells HMGBl is highly dynamic in its 
binding to chromatin, both condensed and decondensed, and rapidly roams throughout 
the nucleus, establishing transient interactions with DNA.
3.7 Mobility of HMGBl within the nucleus of apoptotic cells
The permeabilisation experiments suggested that in apoptosis HMGB 1 might be 
more stably associated with chromatin. I tried to confirm this by measuring the mobility 
of HMGBl in apoptotic cells. FRAP and FLIP analysis performed on TNF-a treated 
cells revealed that HMGBl-GFP is completely immobile in apoptotic cells, not unlike 
in chemically fixed cells (FRAP, Fig. 25A,C; FLIP, Fig. 25B,D). In FRAP experiments, 
after the laser pulse the fluorescence signal was totally lost in the bleached region, and 
no successive recovery was observed. In FLIP experiments, repeated bleaching in the 
same area did not lead to loss of fluorescence in the surrounding regions. These results 
indicate that in apoptosis HMGBl freezes onto chromatin and the binding is so strong 
that virtually no molecule is able to diffuse within the nucleus.
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Fig. 25 Photobleaching analysis in apoptotic cells. Scale bars, 3.7 pm.
A. FRAP. A HeLa cell expressing HMGBl-GFP, forced to undergo apoptosis, was imaged as 
indicated in the legend to Fig. 22. After the laser pulse, no recovery of the fluorescence signal 
was observed in the bleached region (circle), indicating a complete blockade of HMGBl 
movement.
B. FLIP. The spot indicated by a circle was repeatedly bleached for 200 ms in an apoptotic cell. 
Two minutes after the first pulse, no loss of fluorescence was observed outside the bleached 
region, confirming that HMGBl was not moving within the cell.
C D. Kinetics of fluorescence recovery (FRAP) (C) and loss of fluorescence (FLIP) (D) of 
HMGBl-GFP in apoptotic HeLa cells as compared to living cells.
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The blockade of HMGBl mobility in apoptosis is specific, because the mobility 
of GFP-HMGNl, GFP-HMGN2, GFP-NFl, GFP-Hl and GFP alone is not reduced, or 
even increases, in apoptotic cells as compared with living ones (Fig. 26). Thus, the 
condensation and fragmentation of chromatin occurring during apoptosis does not 
impair protein mobility in general.
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Fig. 26 Mobility of unfused GFP and GFP fusions to HMGN2, NFl and histone HI in 
apoptotic cells. FLIP kinetics of unfused GFP, GFP-NFl and GFP-HMGN2, and FRAP 
kinetics of GFP-Hl in apoptotic HeLa cells as compared to living cells. In apoptosis, the 
mobility of unfused GFP and HMGN2 did not change significantly, whereas NFl and HI 
showed even an increase in their mobility. The mobility of HI was measured by FRAP because 
this method is more suitable than FLIP for the analysis of slow proteins.
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3.8 Apoptosis in Hmgbl~^~ cells
The specific tight association of HMGBl with apoptotic chromatin suggested that 
HMGBl might have an active role in the apoptotic process, presumably in modulating 
DNA structure. To check this hypothesis, I forced embryonic fibroblasts obtained from
Hm gbH' and mice into apoptosis, and compared their behaviour. Both cell
lines were equally susceptible to apoptosis, and a morphological analysis did not show 
any evident defect in the chromatin content of apoptotic cells lacking HMGBl. These 
data suggest that the binding of HMGBl to chromatin is not required for apoptosis, but 
rather is a consequence of the process.
Dramatic changes occur in the cell during apoptosis: post-translational modifications 
affect the activity of many proteins, large condensed chromatin bodies form in the 
nucleus and DNA is cleaved at intemucleosomal sites. I tried to understand which of 
these processes is linked to the stable binding of HMGBl to the chromatin of apoptotic 
cells.
3.9 Post-translational modifications of HMGBl in living and apoptotic cells.
HMGBl showed a differential affinity for chromatin in living and apoptotic cells. 
As a first step in trying to elucidate the molecular basis of this difference, I checked 
whether HMGBl itself changes in apoptosis.
When cells undergo apoptosis, many proteins are post-translationally modified. A 
subset of them is irreversibly modified by proteolytic cleavage, the rest is covalently 
modified by phosphorylation, acétylation, méthylation, or similar processes. In the first 
case, key players are apoptotic-specific proteases named caspases, a group of at least
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nine cysteine proteases related to the cell death protein CED-3 in C. elegans (Kumar, 
1995). Caspases are synthesised as inactive zymogens, which are activated during 
apoptosis upon proteolytic cleavage. Active caspases in turn cleave a wide range of 
cellular substrates containing a DXXD sequence, thereby either increasing or abolishing 
their activity (Thombeny et al., 1997).
HMGBl contains a putative double site for caspase cleavage (DEEDEED) at the 
beginning of the acidic tail (Fig. 27A). The removal of this negatively charged region 
would presumably increase the affinity of the protein for DNA, thus I checked whether 
HMGBl is cleaved by active caspases by comparing the molecular weight of the 
protein in living and apoptotic cells. Total extract from control and either TNF-a- 
treated 3T3 or HeLa cells were analysed by Western blot, but no change was seen in 
apoptosis either in the amount of HMGBl or in its molecular weight, ruling out the 
possibility that HMGBl was cleaved by active caspases (Fig. 27B).
I then checked whether covalent modifications could affect the chromatin binding 
properties of HMGB 1 in apoptosis. Old data reported that HMGB 1 is acetylated, and 
that this modification can modulate its DNA binding activity (Johns, 1982; Dimov et 
al., 1990). Tiziana Bonaldi in our lab has recently characterised the acétylation pattern 
of HMGBl, showing that several isoforms with different levels of acétylation are 
present in living cells. Acétylation consists of the addition of acetyl groups (CH3-CO-) 
to the 8  amino group of lysine residues, and leads to the neutralisation of a positive 
charge and modulation of the isoelectric point (pi) of the protein. The process is 
reversible and specific enzymes, acetylases and deacetylases, are responsible, 
respectively, for addition or removal of acetyl groups. Modulation of the total charge of 
a protein by acétylation can dramatically affect its ability to interact with other 
molecules, and contributes to the regulation of its activity (Prives C, 2001; Hung HL,
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1999). It is possible that a deacetylation of HMGBl may increase its affinity for DNA, 
as the net charge of the protein becomes more positive. Therefore, deacetylating 
HMGBl during apoptosis could be a way to stabilize its binding to chromatin. To test 
this possibility, I compared the acétylation status of HMGBl in total extracts obtained 
from living and apoptotic cells, by means of two-dimensional gel electrophoresis (2D 
PAGE). Both in living and apoptotic cells HMGBl was resolved into several isoforms, 
appearing as two spots at the same molecular weight coordinate but corresponding to 
different isoelectric points. The difference between the two isoforms is the number of 
modified lysines and the more basic isoform represents the less acetylated one. 
However, no shift towards basic pl was observed for HMGBl in apoptotic cells as 
compared to living ones, meaning that even the acétylation status of the protein is not 
modified during programmed cell death (Fig. 27C).
In conclusion, this biochemical analysis shows that no changes in HMGB 1 were 
detected in apoptosis, and its tight association to chromatin is unlikely to be due to post- 
translational modifications which increase its affinity to DNA.
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Fig. 27 HMGBl is not differentially modified in living and apoptotic ceUs.
A. Schematic representation of the structure of HMGBl and localisation of the putative 
cleavage site for active caspases.
B. Monodimensional gel electophoresis and Western blot with anti-HMGBl antibodies on total 
extracts obtained from living and apoptotic HeLa cells. The molecular weight of the protein 
does not change in apoptosis, indicating that HMGBl is not cleaved by active caspases.
C. Two-dimensional gel electrophoresis and Western blot with anti-HMGBl antibodies on total 
extracts obtained from living and apoptotic HeLa cells. Multiple acetylated forms of HMGBl 
are visible, but no difference in the pi is detectable between the two samples, meaning that the 
protein is not differentially acetylated during apoptosis.
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3.10 Chromatin changes in apoptosis: effects on HMGBl and its binding to DNA
During apoptosis, both nuclear architecture and chromatin content undergo 
dramatic alterations. Because no variation in HMGBl was detected in apoptosis, I 
focused on these cellular changes to explain the different chromatin binding properties 
of HMGBl in apoptotic cells. In particular, I checked whether apoptotic chromatin 
represents a better substrate for HMGBl, compared with the chromatin of living cells. 
Chromatin condensation and DNA cleavage at intemucleosomal sites are the most 
recognizable markers of apoptosis, even though not many data are available on the 
molecular events underlying these processes. Electron microscopy on isolated apoptotic 
chromatin has shown that the formation of large condensed chromatin domains is 
accompanied by a specific conformational transition at the nucleosome level (Allera et 
al., 1997). Already in the early stages of the process, the core particles appear to be 
tightly packed face-to-face in smooth 11 -nm filaments, at variance with their radial 
disposition around the solenoid axis in the 30-nm fiber (Bednar et al., 1998). These 
filaments progressively fold to generate a closely woven network, which finally 
collapses, producing dense apoptotic bodies (Allera et al., 1997). Simultaneously to 
chromatin condensation, genomic DNA is cleaved at intemucleosomal sites. Two stages 
of DNA degradation are observed. Early in the process, the DNA is cleaved to high 
molecular weight fragments, probably reflecting a large-scale domain organisation of 
the chromatin. Later on, the chromatin is cut into shorter fragments, generating oligo- 
and mononucleosomes (Allera et al., 1997).
I tried to understand whether these alterations in the chromatin content of
apoptotic cells could be responsible for the stable binding of HMGBl. Hmgbl~^~ cells
offered an opportunity to test this hypothesis. Hmghl~/~ fibroblasts were treated with 
TNF-a and cycloheximide, and apoptotic cells detaching from the plate were recovered.
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This cell population, and a control population of non-apoptotic, interphase Hmgbl~^~ 
fibroblasts, were then permeabilised with 0.5% NP-40, and exposed to HMGBl 
produced in E. coli and labelled with Cy5 fluorophore. Microscopic examination 
showed that HMGBl bound to apoptotic nuclei, but not to non-apoptotic ones (Fig. 
28A).
The differential binding of HMGBl to apoptotic vs. non-apoptotic nuclei was also 
confirmed biochemically (Fig. 28B). Permeabilised apoptotic and non-apoptotic
Hmgbl~^~ fibroblasts were incubated with unmodified recombinant HMGBl and 
centrifuged through a discontinuous sucrose gradient. The nuclear pellet, containing 
chromatin free from membrane debris, together with associated HMGBl, was then 
recovered and subjected to electrophoresis. Again, HMGBl appeared associated with 
the apoptotic nuclei, but not with non-apoptotic ones.
These experiments indicated that, upon apoptosis, chromatin undergoes some 
chemical or structural transition that makes it susceptible to HMGBl binding. The 
nature of HMGBl itself, whether endogenous or made in bacteria, chemically modified 
by the addition of fluorophores, or fused to GFP, appears to be irrelevant.
I next investigated the nature of the chromatin modification allowing the stable 
binding of HMGB 1.
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Fig. 28 Chromatin changes occurring in apoptosis create stable binding sites for HMGBl.
Scale bar, 9.5 pm.
A. Hmgbl'^' fibroblasts were permeabilised and incubated with 1 pM recombinant Cy5-labelled 
HMGBl. HMGBl stuck to the apoptotic nucleus (upper) but not to the non-apoptotic one 
(lower).
B. HmgbH" fibroblasts, either undergoing apoptosis or in control untreated cultures were 
permeabilised, mixed with recombinant unlabelled HMGBl and centrifuged through a sucrose 
gradient. Nuclei recovered from the bottom of the tubes were then subjected to SDS-PAGE; 
histones were visualized by Coomassie staining, and HMGBl by immunostaining.
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3.11 Fragmentation of DNA
Because HMGBl binds tightly to reconstituted mononucleosomes in vitro, I 
tested whether the fragmentation of chromatin to oligo- and mononucleosomes 
occurring in vivo in the latest stages of apoptosis would provide stable binding sites for 
HMGBl. With this aim, I tried to dissociate apoptosis from DNA degradation.
To date, the best characterized endonuclease involved in this process in 
vertebrates is the Caspase-activated DNase (CAD, also named as CP ANN or DFF40) 
(Enari et al., 1998; Halenbeck et al., 1998; Liu et al., 1998). CAD is a 40 KDa 
endonuclease which in living cells is found associated with a second polypeptide of 45 
KDa named Inhibitor of CAD (ICAD, or DFF 45) (Liu et al., 1997). ICAD is both a 
folding chaperone and an enzymatic inhibitor of CAD. If CAD is translated in the 
absence of ICAD it adopts an inactive conformation and is catalytically inert (Enari et 
al., 1998). If CAD is translated in the presence of ICAD, it adopts an active 
conformation but is catalytically inactive due to the binding of the ICAD inhibitor. 
Upon induction of apoptosis, ICAD is cleaved in two fragments by caspase-3, and 
releases active CAD (Liu et al., 1997; Sakahira et al., 1998). DNA cleavage during 
apoptosis can be totally blocked by inhibiting CAD activity through the expression of a 
caspase-resistant ICAD. It has been shown however that also overexpression of wild- 
type ICAD can completely block DNA degradation upon apoptotic stimuli, suggesting 
that it is possible to inhibit CAD, just maintaining a small, constant, excess of 
uncleaved ICAD.
HeLa cells were stably transfected with a construct expressing a tagged form of 
wild-type ICAD and treated with TNF-a and cycloheximide. The cells underwent 
apoptosis, showing the characteristic membrane blebbing and chromatin condensation, 
and most ICAD was cleaved by active caspases, so that no full-length protein was
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detectable by Western blot (Fig. 29A). However, the small amount left was sufficient to 
completely inhibit the intemucleosomal cleavage of chromosomal DNA, as verified by 
agarose gel electrophoresis (Fig. 29A). In contrast to control apoptotic cells which 
showed the characteristic DNA ladder, ICAD-overexpressing cells contained intact 
genomic DNA, exactly as living cells. I also confirmed the inhibition of DNA 
degradation at the single cell level. TUNEL staining allows visualization of fluorescent 
nuclei containing fragmented DNA, and is usually used to detect late apoptotic cells. 
Control apoptotic cells were all positive for TUNEL staining, whereas only a 
background signal was observed in apoptotic ICAD-overexpressing cells (Fig. 29B).
ICAD-overexpressing cells offered an opportunity to evaluate the effect of DNA 
degradation on HMGBl binding to apoptotic chromatin, as in this system apoptosis 
occurs without DNA fragmentation. I therefore checked whether the association of 
HMGBl with chromatin could be affected by preventing DNA fragmentation, but I 
found that HMGBl bound equally stably to nonfragmented chromatin and to 
fragmented chromatin (Fig. 29B).
On the basis of this result, we concluded that fragmentation per se is not sufficient 
to create appropriate HMGBl binding sites in apoptotic cells.
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Fig. 29 DNA fragmentation is not responsible for HMGBl binding to apoptotic nuclei
HeLa cells were stably transfected to overexpress a tagged form of ICAD.
A. ICAD-expressing and control cells were induced into apoptosis (apoptotic, lanes 2 and 4), or 
were mock treated (living, lanes 1 and 3). ICAD was visualized by rmmunoblotting with anti- 
FLAG antibodies. ICAD in apoptosis was cleaved by caspase, and lost the FLAG tag (lane 4, 
Western blot). The intemucleosomal cleavage of chromosomal DNA was evident in apoptotic 
wild type cells (lane 2), but was inhibited in apoptotic ICAD-expressing cells (lane 4), as 
visualized by agarose gel electrophoresis.
B. Control and ICAD-expressing cells were treated with TNF-a, permeabilised, fixed and 
stained for DNA and HMGBl. While control apoptotic cells were positive for TUNEL staining, 
indicating genomic DNA fragmentation, apoptotic ICAD-expressing cells were TUNEL- 
negative confirming the inhibition of DNA degradation. Nevertheless, even in the absence of 
DNA cleavage, HMGBl was firmly retained into the nucleus of the cell already showing 
chromatin condensation (white asterisk, lower pannel), as well as into the control apoptotic cells 
( white asterisks, upper panel). Scale bar, 10 pm.
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3.12 Effect of TSA treatment
I next focused on the acétylation status of the apoptotic chromatin. Modulation of 
histone tail acétylation is one of the major mechanisms responsible for the remodelling 
of chromatin structure. The process is under the control of nuclear Histone Acetyl- 
Transferases (HATs) and Histone Deacetylases (HDACs), two families of enzymes 
which respectively add or remove acetyl groups at histones tail lysine residues. Histone 
acétylation destabilizes the chromatin fiber and creates an “open” chromatin 
configuration, making DNA accessible to transcription factors or other DNA binding 
proteins (Davie and Chadee, 1998). In contrast, deacetylation of histones tails facilitates 
chromatin condensation, and generates compact regions, which are usually 
trascriptionally incompetent.
The chromatin acétylation pattern can be altered by inhibiting either HATs or 
HDACs. General inhibitors for both families exist, as well as specific inhibitors for 
individual enzymes (Jung, 2001; Lau et al., 2000). Trichostatin A (TSA) is a general 
deacetylase inhibitor, and treatment of cells with this drug enhances the level of histone 
acétylation (Yoshida et al., 1990).
I added TSA to the medium of HeLa cells just prior to the induction of apoptosis 
and tested the effect of hyperacetylation of apoptotic chromatin on HMGB 1 mobility. 
Both FRAP and FLIP analysis showed that HMGBl binding to apoptotic chromatin was 
suppressed when cells were treated with TSA (Fig. 30A,B). The treatment totally 
reverted the blockade of HMGBl movement in apoptosis and the protein diffused in the 
nucleus with kinetics almost identical to those measured in living cells (Fig. 30C,D). 
This result suggests that hypoacetylation of one or more chromatin components during 
apoptosis is required to allow HMGBl binding.
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Fig. 30 Effect of TSA treatment on HMGBl dynamics in apoptotic cells. Scale bars, 4.7 
pm.
A. FRAP analysis on HeLa cells undergoing apoptosis in the presence o f200 ng/ml TSA. A cell 
was imaged before and during recovery after a single bleaching of a nuclear area (circle), as 
described in the legend to Fig. 22. Most of the fluorescence in the bleached spot was recovered 
already after 1.6 s, indicating that the HMGBl movement in apoptosis was restored in the 
presence of TSA.
B. FLIP. A cell imdergoing apoptosis in the presence of TSA was repeatedly bleached in the 
same spot (indicated by a circle), and imaged between bleach pulses. Complete loss of 
fluorescence was observed also outside the bleached area, confirming the restored mobility of 
HMGBl.
C D. Kinetics of fluorescence recovery (FRAP) (C) and loss of fluorescence (FLIP) (D) of 
HMGBl-GFP in living HeLa cells, as compared to apoptotic cells in the presence and absence 
of TSA. TSA totally reverted the mobility blockade of HMGBl.
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I then checked whether the acétylation status of histones changes in apoptosis. 
Nuclear extracts obtained from living and apoptotic cells were analysed by Western blot 
using antibodies that recognise acetylated lysine residues. Histone H4 from apoptotic 
chromatin appeared to be notably hypoacetylated in comparison to non-apoptotic 
chromatin, whereas no difference was observed in the acétylation status of histones 
H2A, H2B, H3 (Fig. 31A). On the contrary, when cells were treated with TSA, all core 
histones underwent a marked hyperacetylation even in apoptosis (Fig. 31A). H4 
hypoacetylation was also confirmed using a polyclonal antibody raised specifically 
against the acetylated form of the protein (Fig. 31B).
In conclusion, histone H4 is deacetylated during apoptosis, but this deacetylation 
can be prevented by treating the cells with TSA, and upon treatment the binding of 
HMGBl to chromatin is completely abolished.
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Fig. 31 Acétylation status of histones in apoptosis.
A. Total extracts from living cells and cells induced to apoptosis in the presence or in the 
absence of TSA were analysed by Western blot, using polyclonal antibodies specific for 
acetylated-Lysine. In apoptosis, histone H4 was hypoacethlated, but TSA treatment prevented 
H4 deacetylation, inducing hyperacetylation of all histones.
B. Western blot with RIO antibody (specific for the acetylated forms of H4). Protein loading 
was checked by Coomassie staining of identical quantities of extracts.
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3.13 Biological meaning of the capture of HMGBl by apoptotic chromatin
The experiments described above showed that HMGBl has opposite chromatin 
binding properties in dead cells, depending on the mode of cell death: in apoptotic cells 
the protein is specifically retained because it binds stably to hypoacetylated chromatin, 
whereas in necrotic cells HMGBl is not associated with DNA and is released in the 
extracellular medium together with other cellular constituents. I tried to clarify the 
biological meaning of this peculiar behaviour.
3.13.1 Different consequences of cell death: apoptosis versus necrosis
In living organisms, cells die as a part of differentiation and selection processes, 
and through mechanisms that provide for normal cellular turnover. In physiological 
contexts, cells die by apoptosis, which represents an active and programmed death 
process, controlled by intrinsic cellular mechanisms. In contrast, in case of severe 
injury, cells undergo necrosis, which instead is a “passive” and unprogrammed death. 
Under both circumstances, dead cells are rapidly cleared from the body, but through 
different mechanisms and with different consequences.
From a physiological standpoint, apoptotic cell death is primarily distinct from 
necrosis because it occurs without eliciting an inflammatory response (Kerr et al., 
1972). Necrosis is usually the result of trauma, pathologies, poisoning or infection, all 
events that require prompt reaction and damage containment and/or repair. The primary 
damage response in mammals is inflammation. Key players in this process are 
granulocytes and professional phagocytes (macrophages/monocytes and dendritic cells), 
which are activated by cellular components released by necrotic cells, and produce in 
response pro inflammatory cytokines (Fadok et al., 2001). On the contrary, apoptotic
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cells need just to be removed and it is essential that no inflammatory response is 
mounted. In this process as well, phagocytes have a critical role: macrophages and 
dendritic cells recognise and engulf apoptotic cells, without secreting any 
proinflammatory cytokines, and rather produce anti-inflammatory mediators.
Phagocytes discriminate innately between cells that have undergone a 
physiological death and those that have suffered a pathological death (Cocco and Ucker, 
2001). This observation has led to the hypothesis that properties unique to the dying cell 
must determine the mode and outcome of phagocytic clearance.
3.13.2 HMGBl released by necrotic cells stimulates proinflammatory cells in vitro
The binding behaviour of HMGBl clearly distinguishes necrotic and apoptotic 
cells, and might be a good cue to phagocytes, for activating the appropriate responses to 
unprogrammed and programmed cell death. HMGBl has already been reported to be a 
mediator of inflammation (see introduction, paragraph 1.6.1). I then tested directly 
whether the release of HMGBl by dead cells can be the immediate trigger for an 
inflammatory response. Bone marrow cells, containing monocytes in good percentage,
were obtained from wild type mice, and stimulated with dead cells from Hmgbl~^~ or 
wild type fibroblast lines. As expected, wHd type apoptotic cells did not activ-ate 
monocytes, whereas wild type necrotic cells triggered the production of the 
proinflammatory cytokine TNF-a, with a typical bell-shaped dose-effect relationship 
(Fig. 32): TNF-a upregulation is always transient upon monocytes activation, and its 
production rapidly decreases after reaching the peak, in a dose-dependent manner. 
Significantly, Hmgbl~^~ nQCvotic cells were also rather ineffective in eliciting TNF-a
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release, indicating that HMGBl is necessary to promote monocyte activation upon 
necrosis.
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Fig. 32 The release of HMGBl is necessary to promote inflammatory responses. Necrotic 
cells lacking HMGBl do not elicit the production of the proinflammatory TNF-a cytokine by 
monocytes. Necrotic cells or apoptotic cells were incubated for 18 hours at the indicated final 
concentration with monocytes from bone marrow, and TNF-a in the supernatant was assayed by 
ELISA. The experiment was repeated 3 times in tripHcate.
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3.13.3 HMGBl released by necrotic cells triggers inflammation in vivo
I then tried to confirm the role of HMGBl release also in an animal model. I 
could not test whether Hmgbl~^~micQ have a reduced inflammatory response following 
tissue necrosis, because these mice survive only a few hours after birth (Calogero et al.
1999). Therefore, I verified whether injections of anti-HMGBl antibodies can reduce 
inflammatoiy responses in wt mice, following liver necrosis.
Acetaminophen (AAP, also known as paracetamol) is a widely used analgesic and 
antipyretic drug that in toxic doses injures liver in experimental animals and men 
(Thomas, 1993), by depleting glutathione in hépatocytes and causing oxidant stress. 
Histological analysis reveals large areas of liver necrosis, concomitant with local 
inflammation, Kupffer cell activation and the recruitment and sequestration of 
neutrophils and macrophages into the damaged tissue (Lawson et al., 2000). Levels of 
liver damage and neutrophil sequestration are strictly proportional until most 
hepatocytes become necrotic between 12 and 24 hours after AAP poisoning (Lawson et 
al., 2000).
I administered 300 mg/kg AAP with a single intraperitoneal injection to young mice, 
and 9 hours later estimated liver injury by measuring alanine transaminase (ALT) 
activity in serum, and inflammatory cell sequestration by measuring myeloperoxidase 
(MPO) activity in total liver extracts. One control group of mice (n=8) received no AAP, 
one group (n=10) received AAP alone, another (n=6) AAP and affinity purified anti- 
HMGBl antibodies (300 mg/kg), and the last one (n=8) AAP and irrelevant rabbit 
antibodies (300 mg/kg). All 3 groups injected with AAP had elevated ALT levels in 
comparison to sham-treated control, but the differences between the 3 treated groups 
were not statistically significant. Thus, antibodies do not protect against liver damage, at 
least at the onset of the inflammatory response. I then used the MPO/ALT ratio to
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compare inflammatory cell recruitment, normalized to the level of liver damage (Fig. 
33). The mice injected with anti-HMGBl antibodies at the time of AAP poisoning
showed a significantly reduced MPO/ALT ratio ( l.S t 0.3) both in comparison to mice
injected with AAP alone {2.1— 0.3; p<0.05), and to mice injected with AAP and
preimmune rabbit IgGs (2.4^ 0.3; p<0.05). Thus, the experiment shows that anti- 
HMGBl antibodies are effective in reducing inflammation following liver necrosis. No 
HMGBl can derive from activated monocytes and macrophages in our experiment, 
because HMGBl secretion from inflammatory cells requires at least 16 hours (Wang et 
al., 1999; Andersson et al., 2000).
Thus, if HMGBl released by necrotic hepatocytes is blocked with antibodies, the 
inflammatory response to necrosis is significantly reduced.
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Fig. 33 Anti-HMGBl antibodies reduce inflammation caused by necrotic hepatocytes.
Liver injury was induced in one day old mice by acetaminophen (AAP) overdose. One group of 
mice was injected intraperitoneally with AAP alone, one with AAP and affinity purified rabbit 
anti-HMGBl antibodies, and one with AAP and preimmune rabbit antibodies; control mice 
received no AAP. After 9 hours, we assessed liver injury by measuring alanine transaminase 
(ALT) activity in serum, and inflammatory cell recruitment in liver by determining 
myeloperoxidase (MPO) activity in total liver extracts. The data are expressed here as 
MPO/ALT ratios, that indicate relative inflammation normalized to liver damage. Each point 
represents one mouse, the bar indicates the median value, and the grey shade indicates the area 
included within average + standard error. The pairwise comparisons (Mann-Whitney test) 
between the groups of mice that received anti-HMGBl antibodies (green ovals), that did not 
receive antibodies (red diamonds), and that received irrelevant antibodies (violet triangles), is 
indicated below the graph.
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3.13.4 TSA-treated apoptotic cells are proinflammatory
The above experiments prove that HMGBl represents one of the major diffusible 
signals of unprogrammed cell death. However, it cannot test whether apoptotic cells 
escape the inflammatory surveillance because they retain HMGBL Apoptosed cells 
start to leak out cellular components only after several hours, and in vivo they are 
generally cleared by phagocytic cells well before this process (termed secondary 
necrosis) can take place. Therefore, HMGBl retention might appear irrelevant. 
However, some apoptotic cells escape prompt clearance, and remain in tissues till later 
stages. This occurs frequently during development, when many cells synchronously 
undergo apoptosis, and several unengulfed late apoptotic cells can be easily detectable 
by TUNEL staining in tissue sections (Potten, 2001; Hanke, 2000; Imamura et al.,
2000). Under these circumstances, apoptotic cells probably leak out components but no 
inflammatory response is induced, suggesting that a safeguard mechanism should exist.
I then directly tested whether cells undergoing post-apoptotic, secondary necrosis 
would be able to promote inflammatory responses in monocytes. Wild type fibroblasts 
were treated with TNF-a and incubated for 72 hours, until most LDH was released into 
the extracellular medium (see Fig. 18). These post-apoptotic cell remnants, which retain 
HMGBl bound to chromatin, were unable to promote a strong inflammatory response 
in monocytes (Fig. 34). However, when HMGBl binding to chromatin was prevented 
by TSA treatment, secondarily necrotic fibroblasts promoted inflammation as 
vigorously as primary necrotic cells (killed by freeze-thawing).
From all these data, the retention of HMGBl by apoptotic cells undergoing 
secondary necrosis appears to be a safeguard mechanism against the triggering of 
unwanted phlogystic responses.
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Fig. 34 Apoptotic cells that release HMGBl are proinflammatory. Apoptotic cells 
undergoing secondary necrosis and partial autolysis do not promote inflammatory responses, 
unless HMGBl is mobilized by treatment with TSA. Apoptosis of 3T3 fibroblasts was induced 
by TNF-a treatment, in the presence or absence of TSA, for 18 hours at 37°C. Cells were then 
washed to eliminate TSA, and fiuther incubated for 54 hours before challenging monocytes.
TNF-a production after challenge with 0.2 x 10  ^apoptotic cells was considered equal to 1, and 
the other values were normalized accordingly. The experiment was repeated 3 times in 
duplicate, with 2 different amounts of apoptotic cells to be sure that TNF-a production by 
stimulated monocytes would be in the linear range.
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4 DISCUSSION
4.1 Transient interaction of HMGBl with chromatin in living cells
The initial purpose of my thesis work was to characterise the chromatin binding 
properties of HMGBl, in light of the observation that the protein is only loosely bound 
to chromatin in vivo, despite showing a high affinity to nucleosomes in vitro. I 
generated a GFP-tagged HMGBl and used it in combination with photobleaching 
techniques to visualize the dynamics of the protein in living cells. The general 
indication derived from this analysis is that HMGBl is extremely mobile. In interphase 
cells, HMGBl shows a uniform distribution within the nucleus, which is the result of a 
continuous and rapid movement throughout the nucleoplasm. The entire pool of 
HMGBl roams the nucleus, and less then 1.5 seconds are sufficient for one molecule to 
traverse the entire compartment, indicating a very high speed.
High mobility is a general feature of nuclear proteins, including structural 
chromatin proteins, splicing factors, transcription factors and DNA repair enzymes 
(Phair and Misteli, 2000; Misteli, 2001). This recent finding altered an old view of the 
nucleus, considered previously as a viscous, gel-like environment full of nucleic acids 
and proteins. Actually, the volume not accessible to diffusible molecules is less than 
15% (Fushimi and Verkman, 1991), and nuclear proteins can move rapidly within the 
nucleoplasm. Even structural chromatin-binding proteins, thought to be stably bound to 
DNA, are instead in constant flux on DNA. The movement of most nuclear proteins 
appears to be independent of energy (in the form of ATP) and likely occurs by a 
diffusion-based, passive, nondirected mechanism. That is the case for HMGBl too.
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Diffusion is a very effective mode of transport: it is fast, energetically economical and 
does not need any signal to target the molecule to its site.
HMGBl appears to be particularly fast, much more than chromatin proteins like 
HMGN1,2 and histone HI, and transcription factors like NFl. All these proteins have 
similar size and move by diffusion, thus the difference in the effective mobility 
measured by FRAP and FLIP must be due to different networks of interactions 
established by each protein. Generally, incorporation of a protein into a larger complex 
reduces the protein’s apparent mobility, although this has only a small effect unless the 
complex is very large. A second, more important, reason for slowed protein mobility is 
the interaction of proteins with relatively immobile nuclear components, like chromatin 
or the nuclear envelope (Fig. 35A). In light of this, the high mobility of HMGBl is a 
clear indication of the transient nature of its association to chromatin. Indeed, HMGBl 
resides on chromatin at for most 4 seconds before dissociating, suggesting a rapid, 
saltatory movement between chromatin fibers (Fig. 35B). A clear confirmation of this 
“jumping” mode of binding comes from mitotic cells. In mitosis, HMGBl is 
particularly concentrated on chromosomes, but this is not a stable occupancy of 
chromatin sites. Rather, the protein is continuously exchanged between cytoplasm and 
chromosomes and the apparently static association is instead the result of a dynamic 
steady-state. The kinetics of association and-dissociation on DNA are extremely fast, 
and the transient binding of HMGBl to chromosomes does not slow significantly its 
diffusion within the cells.
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Fig. 35 Apparent mobility of nuclear proteins and steady-state occupancy.
A. The mobility of a protein is detennined by its biological properties. Mobility of a monomeric 
protein is higher than for a complexed protein or for a protein that transiently binds to immobile 
components in the nucleus such as chromatin. As proteins diffiise through the nuclear space, 
they are slowed down by their transient interaction with low-affinity binding sites (yellow) 
before they find a specific, high-afOnity site (green).
B. Steady-state occupancy of a chromatin-binding protein is generated by the continuous 
exchange of proteins from the binding site. Replacement of a chromatin-binding protein 
(yellow) with a different factor (red) may induce alterations in chromatin structure (Misteli, 
2001).
What is the meaning of this hectic movement of HMGBl, on and off DNA? 
HMGBl binds DNA in a sequence independent maimer and has no specific target. The 
combination of high mobility and high exchange rate ensures targeting of the protein to 
its site of action by simple diffusion, during which HMGBl effectively scans the 
nucleus for appropriate binding sites. In this view, that HMGBl encounters a particular 
protein or a specific binding site on DNA becomes therefore a chance event, and 
stochastic interactions determine the recruitment of the protein to its binding sites. 
Before finding a high-affinity binding site, HMGB1 is likely to interact with many low- 
affinity sites; however, the high content of HMGBl in the nucleus enhances the 
probability of productive interactions.
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Beyond the fact that this mechanism does not require specific targeting signals, 
another advantage of such a dynamic and probabilistic behaviour of HMGB 1 is the 
potential to respond promptly to external cues modulating its activity. Many different 
processes involve HMGBl, some of them simultaneously, others only under specific 
conditions. If HMGB 1 were statically bound to its targets, mechanisms would have to 
exist to release the protein and make it free for other tasks. The transient nature of its 
interaction instead ensures a high degree of plasticity: the inherent short residence time 
on DNA guarantees repeated availability of HMGB 1 molecules, and the frequency of 
the different interactions can be easily shifted depending on the requirement.
As most nuclear proteins appear to be driven by the same stochastic mechanism in 
their movement, the model might be generalised. Gene transcription, for instance, 
requires sequential interaction of proteins on promoter regions. The probability of 
forming a complex is influenced by the availability and residence time on DNA of each 
assembling component, which, in turn, is determined by its mobility within the nucleus. 
If a factor is not available within the residence time of a previous intermediate, the 
assembly process terminates, and transcription does not occur. The Glucocorticoid 
Receptor (GR), for example, associates only transiently with its target region, residing 
on DNA only a few seconds (McNally et al., 2000). If no HMGBl molecule is recruited 
within the residence time of the GR, the GR dissociates, and the same restriction can be 
extended to all the other factors involved in the process (Fig. 36). Only a fraction of the 
transcriptional attempts therefore are likely to succeed. Nevertheless, the cooperative 
binding of many transcription factors enhances the efficiency of transcription apparatus 
assembly and ensures an adequate rate of transcriptional activation: a single protein 
molecule with an average speed (diffusion coefficient: 0.2-20 pm^sec"^) and an average
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abundance (50,000 copies per cell) encounters a partner molecule of similar abundance 
every 0.5 seconds, and the formation of preassembled modules in the nucleoplasm 
dramatically increases the probability of the machinery assembly on DNA.
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Fig. 36 Stochastic model of gene expression. Assembly of the transcription machinery 
requires targeting of numerous components to specific DNA sequences. The rate of 
transcription is determined by the availabihty of any transcription factor at a locus. The random 
movement of proteins makes assembly stochastic. A transcription activator, like GR, binds 
transiently to its target sequence. If no binding partner is recruited within the residence time of 
the GR, the receptor will dissociate prematurely and no transcription will occur (1). Instead, if a 
binding partner, like HMGBl, is recruited to the site before the GR dissociates, an intermediate 
with a longer residence time will form; in this case, the probability to recruit a third factor 
(yellow) in time is greater and a correct assembly of the machinery may be achieved. The 
dissociation of the bound dimer however is still possible (2). The efficiency of the assembly is 
usually enhanced by protein-protein interactions, which form intermediate already in the 
nucleoplasm: a few preassembled modules with longer residence time associate to DNA, 
reducing the assembly steps, and the cooperative interactions of many proteins enhanced the 
stability of the complex (3).
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Beyond the possibility to scan the nucleus for appropriate binding sites, the 
transient nature of HMGB 1 interaction with chromatin might underlie also a structural 
role, in mediating the dynamics of chromatin itself. When observed by time-lapse 
microscopy, chromatin does not exhibit any dramatic large-scale movements over 
observations periods of several hours. However, biochemical evidence suggests that 
small-scale movements, such as remodelling, of the chromatin fibers occur frequently 
and at all times in vivo. Many ATP-dependent chromatin remodellers have been 
identified (Workman and Kingston, 1998), which mediate relocalisation of intact 
histones octamers on DNA, in a process termed “nucleosome sliding”. The molecular 
mechanism underlying nucleosome movement is unclear, and several models have been 
proposed. According to one of the most supported models, the “bulge” model (Havas et 
al., 2000), during nucleosome sliding, only a small number of DNA-histone bonds are 
broken at any given time, and very short regions of DNA detach from histone octamer, 
forming a “bulge”. Migration of this “bulge” over the surface of the histone octamer 
might lead to a change in the translational position of DNA relative to the histones. 
How nucleosome remodelling machines might facilitate nucleosome mobility through 
the bulging mechanism is not completely understood.
The high affinity for nucleosomes shovm by HMGBl in vitro, and the ability to 
recognise structured DNA, have suggested the possibility that HMGBl may be involved 
in the mechanism of nucleosome sliding. My colleague Tiziana Bonaldi has recently 
substantiated this hypothesis, showing that HMGBl interacts with one of the 
remodelling activities, the ACF complex (ATP dependent Chromatin assembly and 
remodelling Factor) (Ito et al., 1997), and facilitates ACF-mediated chromatin 
remodelling (Bonaldi, unpublished). In the presence of HMGB 1, both the overall yield 
of the nucleosome transition and the kinetics of the process are enhanced. The model
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emerging from these data suggests that HMGBl might catalyse nucleosome sliding by 
binding to the bulge and maintaining it during its movement. This function implicates a 
continuous association/dissociation of HMGBl from DNA, following the single 
nucleosome transitions, whose duration is in the range of milliseconds (Fig. 37).
In light of these observations, a general structural role can actually be assigned to 
HMGBl, even though with a new meaning: HMGBl is not a static component of 
chromatin, involved in packaging of bulk DNA; rather it is a dynamic factor which 
promotes chromatin conformational changes and confers dynamism to the whole 
structure.
Ü
Fig. 37 Bulge model of nucleosome sliding and putative role of HMGBl. HMGBl (yellow) 
might facilitate nucleosome sliding by binding the bulge, and accompanying its movement with 
respect to the core histones. According to this model, HMGBl would dissociate from DNA 
after each nucleosome transition, establishing fleeting but repetitive interactions.
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4.2 Changes in the chromatin binding properties of HMGB 1 during apoptosis
The dynamic behaviour of HMGBl changes completely when cells undergo 
apoptosis, and its movement within the cell is blocked. The interactions established with 
chromatin, which in living cells are transient, in apoptotic cells are extremely stable. 
This phenomenon appears to be specific for HMGBl, because other proteins do not 
show aiiy reduction in their mobility during apoptosis, indicating that condensation of 
apoptotic chromatin does not impair protein mobility in general. The differential 
behaviour of HMGB 1 in living and apoptotic cells is likely not due to changes in post- 
translational modification of the protein. Rather, the causes of HMGBl binding to 
chromatin are chemical and structural alterations in the chromatin that create stable 
binding sites for HMGBl. In particular, histone H4 is deacetylated during apoptosis, 
and the inhibition of this deacetylation by trichostatin A treatment completely abolishes 
HMGBl binding to chromatin.
The high affinity of HMGB 1 to hypoacetylated chromatin might be explained in 
two different ways. One possibility is that HMGBl establishes direct contacts with 
histone H4 and the deacetylated form of H4 is a better partner for HMGBl. However, 
so far, no clear proof of a direct protein-protein interaction has been obtained for the 
two molecules. Moreover, by footprinting analysis it has been shown that the 
preferential binding site for HMGBl in the nucleosome is the linker DNA (Bonaldi et 
al., unpublished), and the most important component in determining the stability of the 
complex appears to be direct interaction with DNA. In light of these observations, we 
cannot rule out the possibility that a physical interaction with the H4 hypoacetylated tail 
might increase the affinity of HMGB 1 to chromatin in apoptosis; however, it appears 
unlikely that this is the major factor involved.
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The second, more likely, possibility is that the deacetylation of histone H4 
determines structural changes in chromatin architecture, which generate stable binding 
sites for HMGBl. Deacetylation of histone tails is generally associated with chromatin 
condensation (Davie and Chadee, 1998), and this is the case for apoptosis too. The 
removal of an acetyl group increases the number of positive charges per nucleosome; 
this increase, in turn, is likely to cause additional base pairs of DNA to interact with 
histone cores, thus forcing the central part of the linker to wind in a compensating right- 
handed toroidal supercoil. In support to this model, electron microscopy studies have 
shown that the basic conformational feature of apoptotic chromatin is the tight face-to- 
face packaging of nucleosomes, which might be a direct consequence of increased 
topological constraints of the linker DNA (Fig. 38) (Allera et al., 1997). In any event, a 
stressed DNA is an excellent substrate for HMGBl, and a strong binding of the protein 
to the supercoiled DNA linker might be a plausible explanation for its stable binding to 
apoptotic chromatin.
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Fig. 38 Differences between “living” and apoptotic chromatin fibers.
A B. Electron micrographs of segments of unfixed, unstained chromatin fibers released fi"om 
nuclei of living chicken erythrocytes into low-salt buffer and observed in the frozen hydrated 
state. Within the fibers, individual nucleosomes are seen in a variety of orientations and appear 
as pear-shaped structures connected by linker DNA (arrow in B) that form “stems” at the entry- 
exit sites (Bednar et al., 1998). Scale bars, 30 nm.
C D. Electron micrographs (C: low magnification, scale bar, 0.2 pm, D: higher magnification, 
scale bar, 0.03 pm) of chromatin isolated at low ionic strength fi*om nuclei of apoptotic 
thymocytes. The arrows in D indicate short regions of the 11-nm filament where core particles 
are sharply imaged. Nucleosomes are tightly associated face-to-face, and linker DNA, invisible, 
is likely to stick out the nucleosomes array, assuming a stressed confirmation (Allera et al., 
1997).
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4.3 HMGBl as a signal of unprogrammed cell death.
I have shown that the binding of HMGB 1 to chromatin depends on the viability of 
the cell. In living cells, the protein is highly dynamic in its binding to both condensed 
and decondensed chromatin. In dying cells, however, this rapid turnover is frozen: in 
apoptotic cells HMGBl is specifically retained by binding stably to hypoacetylated 
chromatin, whereas necrotic cells leak out the protein, together with other cellular 
constituents. The release of HMGB 1 by necrotic cells is actually a direct consequence 
of its transient association with chromatin in living cells. The sudden breakage of the 
membrane, which renders necrotic cells the physiological counterpart of permeabilised 
living cells, causes HMGBl to dilute in the extracellular milieu until all the molecules 
dissociating from chromatin diffuse out. This is therefore a totally passive release of the 
protein.
The opposite behaviour of HMGB 1 in necrosis and apoptosis make it a good clue 
for proinflammatory cells to distinguish between programmed and unprogrammed cell 
death. It is known since Celsius (100 A.D.) that the four cardinal signs of inflammation, 
rubor (redness), calor (heat), tumor (swelling) and dolor (pain), always accompany 
tissue injury, as consequences of increased blood flow to the affected area. 
Nevertheless, despite the well-known correlation between necrosis and inflammation, 
the molecular basis of recognition and reaction to necrotic cells is still unknown. A 
variety of molecules released by lysed cells have been implicated as putative 
recognition elements, including Heat Shock Proteins, ATP and extracellular matrix 
breakdown products (Sauter et al., 2000; Schnurr et al., 2000; Wrenshall et al., 1999), 
but the picture is still blurred and no definitive assignment has been made.
I found that necrotic cells lacking HMGBl are poorly inflammatory, compared to 
wt cells, indicating that HMGBl is one of the most important signals mediating the
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phlogystic response to necrosis. The response is not totally abolished in the absence of 
HMGBl, indicating that it is not the only factor involved in the process. One possibility 
is that HMGB2, which is released by lysed cells (Ronfani, unpublished), might 
cooperate with HMGBl in activating proinflammatory cells and even in the absence of 
HMGBl might determine a minimal response. At the moment, we do not know whether 
HMGB2 has a cytokine activity as well, but considering the high similarity of the two 
proteins, this is likely. Alternatively, other factors, unrelated to HMGBl, might indeed 
have similar functions in inflammation.
In activating proinflammatory cells, HMGBl behaves as one of the long-sought 
“danger signals” to the immune system, as initially proposed in theories of tolerance 
and immunity. The concept of a danger signal was introduced in 1994 as part of a 
model of immunity that suggests that the primary driving force of the immune system is 
not the distinction between self and non-self, but the need to detect and protect against 
danger, both exogenous and endogenous (Matzinger, 1994). In this view, bacteria 
activate the irmate immune system because endotoxins, recognised by macrophages and 
monocytes, signal the exogenous danger. In the same way, necrotic cells stimulate 
proinflammatory cells because released HMGBl is recognised as signal of endogenous 
danger. The signal recognising receptors on professional phagocytes act therefore as 
sentinels of the immune system, which detect hazardous situations.
In the hypothesis that the passive release of HMGB 1 by necrotic cells can be used 
as a simple mechanism of natural immunity, it can be speculated that 
monocytes/macrophages have evolved the ability to actively release the danger signal 
without dying. They secrete HMGBl in response to other stimuli, for example 
endotoxins or proinflammatory cytokines, using it as a late mediator of inflammation in 
case of exogenous danger. In addition, they might also provide an amplification step of
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the HMGBl signal, which acts as an early mediator of the response in case of 
endogenous danger. In this way, even a small amount of HMGBl released by a 
damaged cell would be able to trigger a robust reaction.
In principle, any substance that is normally found inside the cell and that can be 
released upon damage to the plasma membrane, could act as a danger signal; why then 
has HMGBl been “chosen” as the primary message of death? High abundance and 
ubiquitous presence are the first requirements for a robust cue; essentially every cell in 
an organism contains HMGB 1, and about one million molecules of the protein are 
released per cell in the case of necrosis. Core histones, though ubiquitous and even 
more abundant, cannot be signals of damage, as they remain anchored to the insoluble 
chromatin of necrotic cells and are not diffusible. Moreover, a good danger factor must 
be able to differentiate unprogrammed, proinflammatory, cell death from programmed, 
non-inflammatory, death, and HMGBl has indeed opposite behaviours in necrotic and 
apoptotic cells: it is released by necrotic cells, triggering inflammation, whereas it is 
retained by apoptotic cells, tightly bound to chromatin, averting inflammation.
An important point however must be underlined in this context: under normal 
circumstances, apoptotic cells do not release anything at all, because they are rapidly 
cleared by phagocytic cells. Several “eat me” signals are present on the surface of 
apoptotic cells, mediating recognition and uptake by professional phagocytes. One of 
the earlier events occurring to apoptosing cells is the exposure on the outer-membrane 
leaflet of phosphatidylserine, a lipid normally located to the inner leaflet of the plasma 
membrane. As soon as the lipid is exposed, macrophages recognise it through a specific 
receptor, and engulf the dying cells before they lyse (Fadok et al., 2000). In light of that, 
even if HMGB 1 were not sequestered by binding to chromatin, in most cases apoptotic 
cells would not trigger inflammation anyway, because they wouldn’t have time to lyse
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and release HMGBL Thus, HMGBl retention does not appear to be the major 
mechanism to prevent inflammation. Nonetheless, the clearance of apoptotic bodies is 
not totally efficient and some cells routinely escape rapid removal, undergoing 
secondary necrosis. In that case the paralysis of HMGB 1 is necessary. I showed that late 
apoptotic cells, although permeable to soluble molecules, indeed are not as 
inflammatory as primary necrotic cells. Moreover, in further support of our idea, if 
HMGBl is detached from chromatin by TSA treatment, even late apoptotic cells 
become proinflammatory. The real difference therefore is not between necrotic and 
apoptotic cells, but between primary necrotic and secondarily necrotic, late apoptotic 
cells. Uncleared apoptotic cells would be probably much more dangerous than they 
actually are, if HMGB 1 were not retained by chromatin. Thus, the capture of HMGB 1 
represents a safeguard mechanism in case of non-rapid clearance of apoptotic bodies.
4.3.1 Various responses to the traumatic demise of nearby cells.
Proinflammatory cells of the innate immune system are not the only targets of 
released HMGBl, and “chromatin spillage” could be a more general message of death, 
read by all the neighbours of traumatically dead cells.
In collaboration with Angelo Manfredi in our institute, we found that HMGBl can 
also promote dendritic cell maturation. Dendritic cells (DCs) are professional antigen 
presenting cells which take up a diverse array of antigens and present them to T cells, 
initiating the adaptive immune response (Gallucci and Matzinger, 2001). DCs exist in 
two functionally and phenotypically distinct states, immature and mature. Immature 
cells are adept at endocytosis but express relatively low levels of costimulatory 
molecules for T cell activation. Thus, immature DCs, which are mostly present in
peripheral tissue, can take up antigens but do not present them efficiently to T cells.
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After detecting a danger signal, immature DCs transform into mature DCs, cells with a 
reduced capacity for antigen uptake but now with an exceptional capacity for T cell 
stimulation. This transition is accompanied by a dramatic cytoplasmic reorganization 
and migration to lymphoid organs, where T cell priming takes place. Necrotic cells can 
activate DCs, and HMGBl was found to act as a danger signal also in this context. 
Purified HMGBl can induce the maturation of human dendritic cells in vitro, inducing 
upregulation of different markers, including MHC class I and II, with an efficiency at 
least comparable to LPS or TNF-a. The morphological changes associated with 
dendritic cell maturation are also seen, and HMGB 1-challenged DCs are capable of 
priming T cells. In addition, in vivo HMGBl favours the activation of antigen 
presenting cells and the initiation of immune responses, transforming poorly 
immunogenic apoptotic lymphoma cells in efficient vaccines (Rovere et al. 
unpublished). Thus, the release of HMGBl by damaged cells not only induces 
inflammatory responses by macrophages, but also represents a signal to the adaptive 
immune system, which can regulate the balance between immunity and tolerance 
towards intracellular antigens.
Cells not related to the immune system as well can detect the message of death. In 
addition to inflammation, tissue damage promotes tissue repair and remodelling 
processes. We have recently shown that HMGBl elicits migratory responses in vascular 
smooth muscle cells. In case of damage of the endothelium, injured cells release their 
HMGBl both in the bloodstream (possibly causing inflammation of nearby endothelia) 
and towards the intimai layer of the vessel, causing migration and proliferation of 
smooth muscle cells (Degryse et al., 2001). In physiological circumstances this 
contributes to repair the damage. However, this process may also have pathological 
consequences: necrotic cells accumulate in later stages of atherosclerosis, and by
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releasing their HMGBl, they could support a continuous process of inflammation, and 
stimulate smooth muscle cell migration, leading to intima thickening and stenosis. 
More generally, metalloproteinases (MMP), which play an essential role in tissue repair 
facilitating cell migration, are rapidly induced after tissue injury (Li et al., 2001). 
HMGB 1 has been shown to activate MMPs, inducing degradation of the extracellular 
matrix, and thereby promoting wound healing responses to tissue damage (Taguchi et 
al., 2000).
We can also speculate that cancer metastasis (Taguchi et al., 2000) could be 
caused by the release of HMGBl from necrotic cells in the interior of large tumour 
masses. Released HMGBl could be recognised by cancer cells at the periphery of the 
tumor mass, stimulating them to execute dispersal programs.
Finally, also stem cells might use HMGBl to detect dead cells, and start to divide 
replacing the damaged tissue. Experiments are in progress to see whether injection of 
HMGBl in mouse muscles can mimic tissue damage and activate satellite stem cells.
The main issue remaining outstanding is the identity of the receptor which reads 
out the danger signal. To date, the only high-affinity receptor for HMGBl is RAGE, 
which is expressed on a wide range of cellular types, and thus is a good candidate. It has 
been shown that RAGE mediates HMGBl signalling in the migration of vascular cells 
and tumor invasion (Degryse et al., -2001; Taguchi et al., 2000). Also 
macrophages/monocytes express RAGE, and RAGE has been already involved in 
inflammation, as receptor for calgranulin (Hofmann et al., 1999). Nevertheless, a 
considerable body of evidence derived from immunological studies on necrotic cells 
suggests that another receptor could be involved in the process. The Toll-like receptor 
(TLR) family represents a set of at least nine surface molecules essential for recognition 
of microbe-derived products (Akira et al., 2001). Different TLRs are responsible for
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detection of LPS, bacterial DNA, yeast lipopeptides, and through a common pathway, 
which ultimately involves NF-kB, activate host innate immunity against exogenous 
danger. The reaction to endogenous danger, which occurs with very similar formalities, 
might use the same “sentinels”. Indeed, necrotic cells have been identified as potent 
NF-kB inducers, and this activation requires signalling molecules of the TLR pathway 
(Li et al., 2001). Thus, Toll-like receptors could be responsible for mediating HMGBl 
signalling in the inflammatory response.
In conclusion, in light of these data HMGBl puts itself forward as a general 
danger signal that informs cells of the traumatic, non-programmed death of their 
neighbours. This function of HMGB 1 depends on its intrinsic properties of abundance, 
rapid and reversible association with chromatin in living cells, and stickiness to 
apoptotic chromatin.
119
5 REFERENCES
Abraham, E., Arcaroli, J., Carmody, A., Wang, H., and Tracey, K. (2000). HMG-1 as a 
mediator of acute lung inflammation. J Immunol 165, 2950-4.
Adam, 'S. A., Marr, R. S., and Gerace, L. (1990). Nuclear protein import in 
permeabilized mammalian cells requires soluble cytoplasmic factors. J Cell Biol 111, 
807-16.
Aidinis, V., Bonaldi, T., Beltrame, M., Santagata, S., Bianchi, M. E., and Spanopoulou, 
E. (1999). The RAGl homeodomain recruits HMGBl and HMG2 to facilitate 
recombination signal sequence binding and to enhance the intrinsic DNA-bending 
activity of RAG1-RAG2. Mol Cell Biol 19, 6532-42.
Akira, S., Takeda, K., and Kaisho, T. (2001). Toll-like receptors: critical proteins 
linking innate and acquired immunity. Nat Immunol 2, 675-80.
Allera, C., Lazzarini, G., Patrone, E., Alberti, I., Barboro, P., Sanna, P., Melchiori, A., 
Parodi, S., and Balbi, C. (1997). The condensation of chromatin in apoptotic 
thymocytes shows a specific structural change. J Biol Chem 272,10817-22.
Andersson, U., Wang, H., Palmblad, K., Aveberger, A., Bloom, O., Erlandsson-Harris, 
H., Janson, A., Kokkola, R., Zhang, M., Yang, H., and Tracey, K. (2000). High 
Mobility Group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in 
human monocytes. J Exp Med 192, 565-570.
120
Andrei, C., Dazzi, C., Lotti, L., Torrisi, M. R., Chimini, G., and Rubartelli, A. (1999). 
The secretory route of the leaderless protein interleukin Ibeta involves exocytosis of 
endolysosome-related vesicles. Mol Biol Cell 10 ,1463-75.
Bednar, J., Horowitz, R. A., Grigoryev, S. A., Carruthers, L. M., Hansen, J. C., Roster, 
A. J., and Woodcock, C. L. (1998). Nucleosomes, linker DNA, and linker histone form 
a unique structural motif that directs the higher-order folding and compaction of 
chromatin. Proc Natl Acad Sci U S A 9 5 ,14173-8.
Bemhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., 
Manogue, K. R., Cerami, A., and Bucala, R. (1993). MIF is a pituitary-derived cytokine 
that potentiates lethal endotoxaemia. Nature 365, 756-9.
Bianchi, M. E. (1988). Interaction of a protein from rat liver nuclei with cruciform 
DNA. EMBO J. 7, 843-849.
Bianchi, M. E., and Beltrame, M. (2000). Upwardly mobile proteins. Workshop: the 
role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO 
Rep 1, 109-14.
Bianchi, M. E., Beltrame, M., and Falciola, L. (1992). The HMG box motif. In Nucleic 
Acids and Molecular Biology, F. Eckstein and D. M. J. Lilley, eds. (Berlin: Springer 
Verlag), pp. 112-128.
Bianchi, M. E., Beltrame, M., and Paonessa, G. (1989). Specific recognition of 
cruciform DNA by nuclear protein HMGl. Science 243, 1056-9.
Boonyaratanakornkit, V., Melvin, V., Prendergast, P., Altmann, M., Ronfani, L., 
Bianchi, M. E., Taraseviciene, L., Nordeen, S. K., Allegretto, E. A., and Edwards, D. P.
121
3(1998). High-mobility group chromatin proteins 1 and 2 functionally interact with 
steroid hormone receptors to enhance their DNA binding in vitro and transcriptional 
activity in mammalian cells. Mol Cell Biol 18,4471-87.
Bustin, M. (1999). Regulation of DNA-dependent activities by the functional motifs of 
the high-mobility-group chromosomal proteins. Mol Cell Biol 19, 5237-46.
Bustin, M. (2001). Revised nomenclature for high mobility group (HMG) chromosomal 
proteins. Trends Biochem Sci 2 6 ,152-3.
Bustin, M., Lehn, D. A., and Landsman, D. (1990). Structural features of the HMG 
chromosomal proteins and their genes. Biochim Biophys Acta 1049, 231-43.
Calogero, S., Grassi, F., Aguzzi, A., Voigtlander, T., Ferrier, P., Ferrari, S., and 
Bianchi, M. E. (1999). The lack of chromosomal protein Hmgl does not disrupt cell 
growth but causes lethal hypoglycaemia in newborn mice. Nat Genet 22, 276-80.
Clarke, H. J. (1992). Nuclear and chromatin composition of mammalian gametes and 
early embryos. Biochem Cell Biol 70, 856-66.
Cocco, R. E., and Ucker, D. S. (2001). Distinct modes of macrophage recognition for 
apoptotic and necrotic cells are not specified exclusively by phosphatidylserine 
exposure. Mol Biol Cell 72, 919-30.
Crothers, D. M. (1993). Architectural elements in nucleoprotein structures. Curr. Biol 5, 
675-676.
Davie, J. R., and Chadee, D. N. (1998). Regulation and regulatory parameters of histone 
modifications. J Cell Biochem Suppl 31, 203-13.
122
Decoville, M., Giraud-Panis, M. J., Mosrin-Huaman, C., Leng, M., and Locker, D. 
(2000). HMG boxes of DSPl protein interact with the rel homology domain of 
transcription factors. Nucleic Acids Res 28, 454-62.
Degryse, B., Bonaldi, T., Scaffidi, P., Müller, S., Resnati, M., Sanvito, P., Arrigoni, G., 
and Bianchi, M. (2001). The HMG Boxes of the Nuclear Protein HMGl Induce 
Chemotaxis and Cytoskeleton Reorganization in Rat Smooth Muscle Cells. J Cell Biol 
152, 1-12.
Dimitrov, S., Dasso, M. C., and Wolffe, A. P. (1994). Remodeling sperm chromatin in 
Xenopus laevis egg extracts: the role of core histone phosphorylation and linker histone 
B4 in chromatin assembly. J Cell Biol 126, 591-601.
Dimitrov, S. L, Bachvarov, D., and Moss, T. (1993). Mapping of a sequence essential 
for the nuclear transport of the Xenopus ribosomal transcription factor xUBF using a 
simple coupled translation-transport and acid extraction approach. DNA Cell Biol 12, 
275-81.
Dimov, S. L, Alexandrova, E. A., and Beltchev, B. G. (1990). Differences between 
some properties of acetylated and nonacetylated forms of HMGl protein. Biochem 
Biophys Res Commun 166, 819-26.
Enari, M., Sakahira, H., Yokoyama, H., Okawa, K., Iwamatsu, A., and Nagata, S. 
(1998). A caspase-activated DNase that degrades DNA during apoptosis, and its 
inhibitor ICAD. Nature 391,43-50.
123
Fadok, V. A., Bratton, D. L., Guthrie, L., and Henson, P. M. (2001). Differential effects 
of apoptotic versus lysed cells on macrophage production of cytokines: role of 
proteases. J Immunol 166, 6847-54.
Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A., and Henson, 
P. M. (2000). A receptor for phosphatidylserine-specific clearance of apoptotic cells. 
Nature 405, 85-90.
Pages, C., Nolo, R., Huttunen, H., Eskelinen, E., and Rauvala, H. (2000). Regulation of 
cell migration by amphoterin. J Cell Sci 775, 611-20.
Falciola, L., Murchie, A. I., Lilley, D. M., and Bianchi, M. (1994). Mutational analysis 
of the DNA binding domain A of chromosomal protein HMGL Nucleic Acids Res 22, 
285-92.
Fushimi, K., and Verkman, A. S. (1991). Low viscosity in the aqueous domain of cell 
cytoplasm measured by picosecond polarization microfluorimetry. J Cell Biol 112, 719- 
25.
Gallucci, S., and Matzinger, P. (2001). Danger signals: SOS to the immune system. 
Curr Opin Immunol 75,114-9.
Ge, H., and Roeder, R. G. (1994). The high mobility group protein HMGl can 
reversibly inhibit class II gene transcription by interaction with the TATA-binding 
protein. J Biol Chem 269,17136-40.
Goodfellow, P. N., and Lovell-Badge, R. (1993). SRY and sex determination in 
mammals. Annu Rev Genet 27, 71-92.
124
Halenbeck, R., MacDonald, H., Roulston, A., Chen, T. T., Conroy, L., and Williams, L. 
T. (1998). CP AN, a human nuclease regulated by the caspase-sensitive inhibitor 
DFF45. Curr Biol 8, 537-40.
Hanke, J. (2000). Apoptosis and occurrence of Bcl-2, Bak, Bax, Fas and FasL in the 
developing and adult rat endocrine pancreas. Anat Embryol (Berl) 202, 303-12.
Hardman, C. H., Broadhurst, R. W., Raine, A. R., Crasser, K. D., Thomas, J. O., and 
Laue, E. D. (1995). Structure of the A-domain of HMGl and its interaction with DNA 
as studied by heteronuclear three- and four-dimensional NMR spectroscopy. 
Biochemistry 5^, 16596-607.
Havas, K., Flaus, A., Phelan, M., Kingston, R., Wade, P. A., Lilley, D. M., and Owen- 
Hughes, T. (2000). Generation of superhelical torsion by ATP-dependent chromatin 
remodeling activities. Cell 103, 1133-42.
Heim, R, Prasher, D.C., Tsien, R.Y. (1994). Wavelength mutations and posttranslational 
autoxidation of green fluorescent protein. Proc Natl Acad Sci USA.  91(26), 12501-4.
Heim, R., Tsien R.Y. (1996). Engineering green fluorescent protein for improved 
brightness, longer wavelengths and fluorescence resonance energy transfer. Curr Biol. 6 
(2), 178-82.
Hofmann, M. A., Drury, S., Fu, C., Qu, W., Taguchi, A., Lu, Y., Avila, C., Kambham, 
N., Bierhaus, A., Nawroth, P., Neurath, M. F., Slattery, T., Beach, D., McClary, J., 
Nagashima, M., Morser, J., Stem, D., Schmidt, A. M. (1999). RAGE mediates a novel 
proinflammatory axis: a central cell surface receptor for SlOO/calgranulin polypeptides. 
Cell 97, 889-901
125
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, 
E. R., Vijay, S., Nitecki, D., Morser, D., Stem, D., and Schmidt, A. M. (1995). The 
receptor for advanced glycation end products (RAGE) is a cellular binding site for 
amphoterin. J. Biol. Chem. 270,25752-25761.
Hung, H.L., Lau, J., Kim, A.Y., Weiss, M.J., Blobel, G.A. (1999). CREB-Binding 
protein acetylates hematopoietic transcription factor GATA-1 at functionally important 
sites. Mol Cell Biol. 19 (5), 3496-505.
Huttunen, H., Pages, C., and Rauvala, H. (1999). Receptor for advanced glycation end 
products (RAGE)-mediated neurite outgrowth and activation of NF-kB require the 
cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol 
Chem 274, 19919-24.
Imamura, S., Nishikawa, T., Hiratsuka, E., Takao, A., and Matsuoka, R. (2000). 
Behavior of smooth muscle cells during arterial ductal closure at birth. J Histochem 
Cytochem 48, 35-44.
Ito, T., Tyler, J. K., and Kadonaga, J. T. (1997). Chromatin assembly factors: a dual 
function in nucleosome formation and mobilization? Genes Cells 2, 593-600.
Jayaraman, L., Moorthy, N. C., Murthy, K. G., Manley, J. L., Bustin, M., and Prives, C. 
(1998). High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes 
Dev 72, 462-72.
Johns, E. W. (1982). The HMG chromosomal proteins (London: Academic Press).
126
Jones, D. N., Searles, M. A., Shaw, G. L., Churchill, M. E., Ner, S. S., Keeler, J., 
Travers, A. A., and Neuhaus, D. (1994). The solution structure and dynamics of the 
DNA-binding domain of HMG-D from Drosophila melanogaster. Structure 2, 609-27.
Jung, M. (2001). Inhibitors of histone deacetylase as new anticancer agents. Curr Med 
Chem 8 ,1505-11.
Kato, A., Yoshidome, H., Edwards, M. J. and Lentsch, A. B. (2000). Regulation of liver 
inflammatory injury by signal transducer and activator of transcription-6. Am. J. Pathol. 
157: 297-302
Kerr, J. F., Wyllie, A. H., and Currie, A. R. (1972). Apoptosis: a basic biological 
phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 26, 239-57.
Kolodrubetz, D., and Burgum, A. (1990). Duplicated NHP6 genes of Saccharomyces 
cerevisiae encode proteins homologous to bovine high mobility group protein 1. J Biol 
Chem 265, 3234-9.
Kumar, S. (1995). ICE-like proteases in apoptosis. Trends Biochem Sci 2 0 ,198-202.
Lau, O. D., Kundu, T. K., Soccio, R. E., Ait-Si-Ali, S., Khalil, E. M., Vassilev, A., 
Wolffe, A. P., Nakatani, Y., Roeder, R. G., and Cole, P. A. (2000). HATs off: selective 
synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol Cell 5, 589- 
95.
Lawson, J. A., Farhood, A., Hopper, R. D., Bajt, M. L. and Jaeschke, H. (2000). The 
hepatic inflammatory response after acetaminophen overdose: role of neutrophils. 
Toxicol Sci. 54, 509-516
127
Lever, M. A., Th'ng, J. P., Sun, X., and Hendzel, M. J. (2000). Rapid exchange of 
histone H l.l on chromatin in living human cells. Nature 408, 873-6.
Li, J., Qu, X., and Schmidt, A. (1998). Spl-binding elements in the promoter of RAGE 
are essential for amphoterin-mediated gene expression in cultured neuroblastoma cells. 
J Biol Chem 275, 30870-8.
Li, M., Carpio, D. F., Zheng, Y., Bruzzo, P., Singh, V., Ouaaz, F., Medzhitov, R. M., 
and Beg, A. A. (2001). An essential role of the NF-kB/Toll-like receptor pathway in 
induction of inflammatory and tissue-repair gene expression by necrotic cells. J 
Immunol 166, 7128-35.
Lilley, D. M. (1992). DNA-protein interactions. HMG has DNA wrapped up. Nature 
557,282-3.
Liu, X., Li, P., Widlak, P., Zou, H., Luo, X., Garrard, W. T., and Wang, X. (1998). The 
40-kDa subunit of DNA fragmentation factor induces DNA fragmentation and 
chromatin condensation during apoptosis. Proc Natl Acad Sci U S A 95, 8461-6.
Liu, X., Zou, H., Slaughter, C., and Wang, X. (1997). DFF, a heterodimeric protein that 
functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis. Cell 
8 9 ,175-84.
Maniatis, T., Fritsch, E. F. and Sambrook, J. (1989). Molecular cloning: a laboratory 
manual: Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
Matzinger, P. (1994). Tolerance, danger, and the extended family. Annu Rev Immunol 
12, 991-1045.
128
McNally, J. G., Muller, W. G., Walker, D., Wolford, R., Hager, G. L. (2000). The 
glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 
2,57,1262-5.
Misteli, T., Gunjan, A., Hock, R., Bustin, M., and Brown, D. T. (2000). Dynamic 
binding of histone HI to chromatin in living cells. Nature 408, 877-81.
Misteli T. (2001). Protein dynamics: implications for nuclear architecture and gene 
expression. Science 291, 843-7.
Mistry, A., Falciola, L., Monaco, L., Tagliabue, R., Acerbis, G., Knight, A., Harbottle, 
R. P., Soria, M., Bianchi, M. E., Coutelle, C., and Hart, S. L. (1997). Recombinant 
HMGl protein produced in Pichia pastoris: a non-viral gene delivery agent. 
Biotechniques 22, 718-729.
Murphy, F. V., Sweet, R. M., and Churchill, M. E. (1999). The structure of a 
chromosomal high mobility group protein-DNA complex reveals sequence-neutral 
mechanisms important for non-sequence-specific DNA recognition. EMBO J 18, 6610- 
8 .
Ner, S. S., and Travers, A. A. (1994). HMG-D, the Drosophila melanogaster homologue 
of HMG 1 protein, is associated with early embryonic chromatin in the absence of 
histone HI. EMBO J 13 ,1817-22.
Nightingale, K., Dimitrov, S., Reeves, R., and Wolffe, A. P. (1996). Evidence for a 
shared structural role for HMGl and linker histones B4 and HI in organizing 
chromatin. EMBO J 15, 548-61.
129
Ohndorf, U. M., Rould, M. A., He, Q., Pabo, C. 0., and Lippard, S. J. (1999). Basis for 
recognition of cisplatin-modified DNA by high-mobility-group proteins. Nature 399, 
708-12.
Ormô, M., Cubitt, A.B., Kallio, K., Gross, L.A., Tsien, R.Y., Remington, S.J. (1996) 
Crystal structure of the Aequorea victoria green fluorescent protein. Science. 
273(5280):1392-5.
Parkkinen, J., and Rauvala, H. (1991). Interactions of plasminogen and tissue 
plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed 
plasminogen activation by amphoterin. J Biol Chem 266,16730-5.
Passalacqua, M., Patrone, M., Picotti, G., Del Rio, M., Sparatore, B., Melloni, E., and 
Pontremoli, S. (1998). Stimulated astrocytes release high-mobility group 1 protein, an 
inducer of LAN-5 neuroblastoma cell differentiation. Neuroscience 8 2 ,1021-8.
Passalacqua, M., Zicca, A., Sparatore, B., Patrone, M., Melloni, E., and Pontremoli, S.
(1997). Secretion and binding of HMG 1 protein to the external surface of the membrane 
are required for murine erythroleukemia cell differentiation. FEBS Lett 400,275-9.
Prasher, D.C. (1995) Using GFP to see the light. Trends Genet. 11 (8), 320-3
Phair, R. D., and Misteli, T. (2000). High mobility of proteins in the mammalian cell 
nucleus. Nature 404, 604-9.
Phair, R. D., and Misteli, T. (2001). Kinetic modelling approaches to in vivo imaging. 
Nat Rev Mol Cell Biol. 2 (12), 898-907
130
Pii, P. M., Chow, C. S., and Lippard, S. J. (1993). High-mobility-group 1 protein 
mediates DNA bending as determined by ring closures. Proc Natl Acad Sci U S A 90, 
9465-9.
Pil, P. M., and Lippard, S. J. (1992). Specific binding of chromosomal protein HMGl to 
DNA damaged by the anticancer drug cisplatin. Science 256,234-7.
Potten, C. S. (2001). Apoptosis in oral mucosa: lessons from the crypt. A commentary. 
Oral Dis 7, 81-5.
Prives, C., Manley, J.L. (2001) Why is p53 acetylated? Cell 107 (7), 815-8
Read, C. M., Cary, P. D., Crane-Robinson, C., Driscoll, P. C., and Norman, D. G. 
(1993). Solution structure of a DNA-binding domain from HMGL Nucleic Acids Res 
21, 3427-36.
Ronfani, L., Ferraguti, M., Croci, L., Ovitt, C. E., Scholer, H. R., Consalez, G. G., and 
Bianchi, M. E. (2001). Reduced fertility and spermatogenesis defects in mice lacking 
chromosomal protein Hmgb2. Development 128,1265-73.
Rouhiainen, A., Imai, S., Rauvala, H., and Parkkinen, J. (2001). Occurrence of 
amphoterin (HMGl) as an endogenous protein of humanplatelets that is exported to the 
cell surface upon platelet activation. Thromb Haemost 84 ,1087-94.
Sakahira, H., Enari, M., and Nagata, S. (1998). Cleavage of CAD inhibitor in CAD 
activation and DNA degradation during apoptosis. Nature 391, 96-9.
Sauter, B., Albert, M. L., Francisco, L., Larsson, M., Somersan, S., and Bhardwaj, N. 
(2000). Consequences of cell death: exposure to necrotic tumor cells, but not primary
131
tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic 
cells. J Exp Med 191, 423-34.
Schatz, D. G., Gettinger, M. A., and Baltimore, D. (1989). The V(D)J recombination 
activating gene, RAG-1. Cell 59, 1035-48.
Schmidt, A., Yan, S., Yan, S., and Stem, D. (2000). The biology of the receptor for 
advanced glycation end products and its ligands. Biochim Biophys Acta 1498, 99-111.
Schnurr, M., Then, F., Galambos, P., Scholz, C., Siegmund, B., Endres, S., and Eigler, 
A. (2000). Extracellular ATP and TNF-a synergize in the activation and maturation of 
human dendritic cells. J Immunol 165,4704-9.
Shykind, B. M., Kim, J., and Sharp, P. A. (1995). Activation of the TFIID-TFIIA 
complex with HMG-2. Genes Dev 9 ,1354-65.
Spada, F., Bmnet, A., Mercier, Y., Renard, J. P., Bianchi, M. E., and Thompson, E. M.
(1998). High mobility group 1 (HMGl) protein in mouse preimplantation embryos. 
Mech Dev 76, 57-66.
Sparatore, B., Passalacqua, M., Patrone, M., Melloni, E., and Pontremoli, S. (1996). 
Extracellular high-mobility group 1 protein is essential for murine erythroleukaemia cell 
differentiation. Biochem J. 320, 253-6.
Sutrias-Grau, M., Bianchi, M. E., and Bemues, J. (1999). High mobility group protein 1 
interacts specifically with the core domain of human TATA box-binding protein and 
interferes with transcription factor IIB within the pre-initiation complex. J Biol Chem 
274, 1628-34.
132
Taguchi, A., Blood, D. C., del Toro, G., Canet, A., Lee, D. C., Qu, W., Tanji, N., Lu, 
Y., Lalla, E., Fu, C., Hofmann, M. A., Kislinger, T., Ingram, M., Lu, A., Tanaka, H., 
Hori, O., Ogawa, S., Stem, D., and Schmidt, A. M. (2000). Blockage of RAGE- 
amphoterin signalling suppresses tumour growth and metastasis. Nature 405, 354-360.
Thomas, S. H. L. (1993). Paracetamol (acetaminophen) poisoning.. Pharmacol. Then 
60, 91-120.
Thomberry, N. A., Rano, T. A., Peterson, E. P., Rasper, D. M., Timkey, T., Garcia- 
Calvo, M., Houtzager, V. M., Nordstrom, P. A., Roy, S., Vaillancourt, J. P., Chapman, 
K. T., and Nicholson, D. W. (1997). A combinatorial approach defines specificities of 
members of the caspase family and granzyme B. Functional relationships established 
for key mediators of apoptosis. J Biol Chem 272,17907-11.
Tracey, K. J., and Cerami, A. (1993). Tumor necrosis factor, other cytokines and 
disease. Annu Rev Cell Biol P, 317-43.
Travers, A. A., Ner, S. S., and Churchill, M. E. (1994). DNA chaperones: a solution to a 
persistence problem? Cell 77,167-9.
Tsien, R. and Waggoner, A. (1995). Handbook of Confocal Fluorescence Microscopy, 
Plenum Press. Edition, Volume 10, J. Pawley, ed.
Ura, K., Nightingale, K., and Wolffe, A. P. (1996). Differential association of HMGl 
and linker histones B4 and HI with dinucleosomal DNA: stmctural transitions and 
transcriptional repression. EMBO J 15, 4959-69.
Yaccari, T., Beltrame, M., Ferrari, S., and Bianchi, M. E. (1998). Hmg4, a new member 
of the Hmgl/2 gene family. Genomics 49, 247-52.
133
Varga-Weisz, P., van Holde, K., and Zlatanova, J. (1993). Preferential binding of 
histone HI to four-way helical junction DNA. J Biol Chem 268,20699-700.
Verbeek, S., Izon, D., Hofhuis, F., Robanus-Maandag, E., te Riele, H., van de Wetering, 
M., Oosterwegel, M., Wilson, A., MacDonald, H. R., and Clevers, H. (1995). An HMG- 
box-cofitaining T-cell factor required for thymocyte differentiation. Nature 374, 70-4.
Wagner, C. R., Hamana, K., and Elgin, S. C. (1992). A high-mobility-group protein and 
its cDNAs from Drosophila melanogaster. Mol Cell Biol 12, 1915-23.
Wang, H., Bloom, O., Zhang, M., Vishnubhakat, J. M., Ombrellino, M., Che, J., 
Frazier, A., Yang, H., Ivanova, S., Borovikova, L., Manogue, K. R., Faist, E., Abraham, 
E., Andersson, J., Andersson, U., Molina, P. E., Abumrad, N. N., Sama, A., and Tracey, 
K. J. (1999a). HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 
248-51.
Wang, H., Vishnubhakat, J., Bloom, O., Zhang, M., Ombrellino, M., Sama, A., and 
Tracey, K. (1999b). Proinflammatory cytokines (tumor necrosis factor and interleukin 
1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 126, 389- 
92.
Weir, H. M., Kraulis, P. J., Hill, C. S., Raine, A. R., Laue, E. D., and Thomas, J. O. 
(1993). Structure of the HMG box motif in the B-domain of HMGL EMBO J 72, 1311- 
9.
Werner, M. H., Huth, J. R., Gronenbom, A. M., and Clore, G. M. (1995). Molecular 
basis of human 46X,Y sex reversal revealed from the three- dimensional solution 
structure of the human SRY-DNA complex. Cell 81, 705-14.
134
Wisniewski, J. R., and Grossbach, U. (1996). Structural and functional properties of 
linker histones and high mobility group proteins in polytene chromosomes. Int J Dev 
Biol 40,177-87.
Wolffe, A. P. (1999). Architectural regulations and Hmgl. Nat Genet 22,215-7.
Workman, J. L., and Kingston, R. E. (1998). Alteration of nucleosome structure as a 
mechanism of transcriptional regulation. Annu Rev Biochem 67, 545-79.
Wrenshall, L. E., Stevens, R. B., Cerra, F. B., and Platt, J. L. (1999). Modulation of 
macrophage and B cell function by glycosaminoglycans. J Leukoc Biol 66, 391-400.
Yoshida, M., Kijima, M., Akita, M., and Beppu, T. (1990). Potent and specific 
inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A. 
J Biol Chem 265,17174-9.
Zappavigna, V., Falciola, L., Helmer-Citterich,, M., Mavilio, F., and Bianchi, M. E. 
(1996). HMGl interacts with HOX proteins and enhances their DNA binding and 
transcriptional activation. EMBO J 15, 4981-91.
Zlatanova, J., Leuba, S. H., and van Holde, K. (1999). Chromatin structure revisited. 
Crit Rev Eukaryot Gene Expr 9, 245-55.
Zwilling. S., Konig, H., and Wirth, T. (1995). High mobility group protein 2 
functionally interacts with the POU domains of octamer transcription factors. EMBO J 
14 ,1198-208.
135
